{"gene":"RAC1","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2002,"finding":"Activated Rac1 (and Cdc42) interacts with IQGAP1, and IQGAP1 in turn binds CLIP-170, forming a tripartite Rac1/Cdc42–IQGAP1–CLIP-170 complex that captures microtubule plus-ends at the cortical leading edge to polarize the microtubule array and establish cell polarity. Expression of an IQGAP1 mutant defective in Rac1/Cdc42 binding induces multiple leading edges.","method":"Co-immunoprecipitation, GFP-fusion live imaging, dominant-negative/truncation expression in Vero fibroblasts","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, functional rescue/dominant-negative, live imaging; findings replicated across multiple constructs in a single rigorous study","pmids":["12110184"],"is_preprint":false},{"year":1999,"finding":"The Salmonella Typhimurium effector SptP acts as a GAP (GTPase-activating protein) directly for Rac-1 and Cdc42, stimulating GTP hydrolysis and thereby reversing the actin cytoskeletal changes (membrane ruffling) induced by bacterial invasion.","method":"In vitro GAP assay with purified SptP and Rac-1/Cdc42, cell-based phenotypic rescue","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro biochemical assay with purified proteins demonstrating GAP activity; published in high-tier journal with clear mechanistic read-out","pmids":["10499590"],"is_preprint":false},{"year":1997,"finding":"Both Rac1 and Cdc42 are required for FcγR-mediated phagocytosis and for membrane ruffling in macrophages; dominant-inhibitory Rac1 N17 blocks phagocytic cup formation and particle internalization without fully blocking F-actin accumulation, indicating a role downstream of actin recruitment in membrane remodeling.","method":"Expression of dominant-negative Rac1 N17 and Cdc42 N17 in transfected RAW 264.7 macrophages; F-actin staining; phagocytosis assay","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean dominant-negative loss-of-function with defined phagocytic phenotype, replicated across multiple receptor stimuli","pmids":["9348306"],"is_preprint":false},{"year":1998,"finding":"Dominant-inhibitory Rac1 blocks particle internalization and prevents phagocytic cup closure during FcεRI-mediated phagocytosis in RBL-2H3 mast cells; Rac1 and CDC42 have distinct functions (Rac1-inhibited cells show thin membrane protrusions that fail to fuse, while CDC42-inhibited cells show pedestal-like structures), and inhibition of both is accompanied by persistence of phosphotyrosine around bound particles, suggesting Rac1 coordinates actin organization and membrane extension.","method":"Stable transfection of dominant-negative Rac1 and CDC42 in RBL-2H3 cells; F-actin staining; phagocytosis assay; phosphotyrosine immunofluorescence","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — stable dominant-negative cell lines with orthogonal phenotypic readouts (phagocytosis, morphology, phosphotyrosine); independent replication of the Rac1 phagocytosis requirement","pmids":["9799231"],"is_preprint":false},{"year":1996,"finding":"Rac1 is a required downstream component of the Vav oncogene signaling pathway that activates JNK/SAPK; co-expression of dominant-inhibitory Rac1 N17 dramatically reduces JNK/SAPK stimulation by oncogenic Vav and reduces Vav-induced focus formation in NIH3T3 cells, establishing Rac1 as an effector linking Vav (a Rho-family GEF) to the JNK/SAPK kinase cascade.","method":"Transient co-expression in COS-7 cells; JNK/SAPK kinase assay; focus-formation assay in NIH3T3 cells with dominant-negative Rac1","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis via dominant-negative plus kinase activity assay; single lab but two independent functional readouts","pmids":["8760286"],"is_preprint":false},{"year":1998,"finding":"Rac1 C-terminus (polybasic region) is necessary and sufficient to constitutively associate with a type I PtdInsP 5-kinase and a diacylglycerol kinase (DGK) independent of GTP-loading; RhoGDI associates with this lipid kinase complex primarily via its interaction with Rac1; specific phospholipids enhance the Rac–lipid kinase interaction.","method":"In vitro binding with chimeric/truncation/peptide Rac1 constructs; co-purification by liquid chromatography; in vivo co-immunoprecipitation with RhoGDI","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with domain mapping (chimeras, peptides, truncations) plus reciprocal co-IP; single lab with multiple orthogonal biochemical methods","pmids":["9447972"],"is_preprint":false},{"year":1996,"finding":"Rac1, in its GTP-bound form, directly binds alpha- and beta-tubulin via its effector domain (D38A mutation abolishes interaction); GTPase-dead mutants G12V and Q61L retain tubulin binding, indicating the interaction requires the active conformation but not GTP hydrolysis.","method":"Overlay binding assay with [γ-32P]GTP-labeled Rac1 on cell extract nitrocellulose; purification and identification of 55-kDa binding proteins as tubulin; binding assay with purified tubulin and Rac1 point mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified tubulin, systematic effector-domain mutagenesis; single lab but rigorous biochemical controls","pmids":["8631991"],"is_preprint":false},{"year":2000,"finding":"Membrane recruitment of activated Rac1 alone is sufficient to trigger actin polymerization and phagocytic particle internalization; the Rac1 effector-loop mutation F37L abolishes this activity, demonstrating that phagocytosis requires downstream effector binding by Rac1.","method":"Rapamycin-inducible membrane-recruitment system (FKBP–FRB bridge) for activated Rac1; actin immunofluorescence; latex bead internalization assay; cytochalasin D inhibition; site-directed mutagenesis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution via inducible membrane-targeting with effector-loop mutagenesis; clean mechanistic design in a single rigorous study","pmids":["10934035"],"is_preprint":false},{"year":2003,"finding":"Genetic deletion of both Rac1 and Rac2 in mice causes massive egress of hematopoietic stem/progenitor cells from bone marrow; Rac1 specifically (not Rac2) is required for HSC/P engraftment in irradiated recipients; Rac2 (not Rac1) regulates superoxide production and directed neutrophil migration, demonstrating non-redundant isoform-specific roles.","method":"Conditional gene targeting (Rac1−/−, Rac2−/−, Rac1/2 double KO) in mice; bone marrow transplantation; NADPH oxidase/superoxide assay; migration assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with multiple defined in vivo and in vitro phenotypic readouts; isoform specificity established by parallel KO comparison","pmids":["14564009"],"is_preprint":false},{"year":2005,"finding":"Conditional deletion of Rac1 in adult mouse epidermis drives epidermal stem cells to divide and undergo terminal differentiation; Rac1 exerts this effect by negatively regulating c-Myc through PAK2 phosphorylation, placing Rac1 upstream of PAK2 and c-Myc in the stem cell regulatory axis.","method":"Inducible conditional Rac1 KO in mouse epidermis; histology; BrdU incorporation; immunostaining for c-Myc and PAK2; epistasis analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with defined stem cell phenotype plus pathway placement via PAK2–c-Myc epistasis in a single rigorous in vivo study","pmids":["16081735"],"is_preprint":false},{"year":2006,"finding":"Rac1 is required in cardiomyocytes for NADPH oxidase activation and cardiac hypertrophy: cardiac-specific Rac1 deletion abolishes gp91(phox)–p67(phox) interaction, reduces NADPH oxidase activity and myocardial oxidative stress, and attenuates angiotensin II–induced hypertrophy in vivo.","method":"Cardiomyocyte-specific inducible Rac1 KO mice; co-immunoprecipitation of gp91(phox) and p67(phox); NADPH oxidase activity assay; ROS measurement; echocardiography","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple orthogonal biochemical readouts (co-IP, enzyme activity, ROS) plus in vivo hypertrophic phenotype","pmids":["16651530"],"is_preprint":false},{"year":2007,"finding":"Rac1 signaling promotes chondrogenesis and N-cadherin expression in mesenchymal precursors; pharmacological or genetic inhibition of Rac1 reduces Sox9/Sox5/Sox6 transcription factor expression and cartilage markers, while Rac1 overexpression increases them; Rac1 and Cdc42 act through partially distinct mechanisms during chondrogenesis.","method":"Pharmacological Rac1 inhibition and dominant-active overexpression in micromass cultures and ATDC5 cells; conditional Rac1 KO primary micromass cultures; RT-PCR; immunoblot; N-cadherin staining","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus gain-of-function with multiple molecular readouts; single lab","pmids":["17573353"],"is_preprint":false},{"year":2005,"finding":"Rac1 and Cdc42 promote chondrocyte hypertrophy and apoptosis through activation of the p38 MAP kinase pathway; pharmacological p38 inhibition blocks the effects of Rac1 and Cdc42 overexpression on hypertrophy and apoptosis, and Rac1/Cdc42 activity is required for maximal collagen X promoter activity, antagonizing RhoA signaling.","method":"Transient/stable transfection in primary chondrocytes and ATDC5 cells; luciferase reporter; TUNEL assay; caspase activity; phospho-p38 immunoblot; p38 inhibitor epistasis","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis via pharmacological inhibitor plus gain-of-function with multiple orthogonal readouts; single lab","pmids":["15883643"],"is_preprint":false},{"year":2012,"finding":"The centralspindlin component CYK4 functions as a GAP specifically for Rac1 (not RhoA) at the cell equator during anaphase; CYK4 GAP activity suppresses Rac1-dependent ARHGEF7 and PAK1 effector pathways required for cell adhesion, thereby spatially segregating cell adhesion from contractile ring activity during cytokinesis.","method":"In vitro GAP assay with purified CYK4; CYK4 GAP mutant expression; depletion of ARHGEF7/PAK1 rescue experiments; vinculin staining; cytokinesis phenotyping","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro GAP activity assay plus genetic epistasis rescue; mechanism supported by both biochemistry and cell biology","pmids":["22945935"],"is_preprint":false},{"year":2006,"finding":"p66shc increases the Rac1-specific GEF activity of Sos1 by displacing Sos1 from Grb2 (via competition of the PPLP motif in the p66shc CH2 domain for the C-SH3 domain of Grb2) and promoting formation of the Sos1–Eps8–E3b1 tricomplex, resulting in Rac1 activation and oxidative stress.","method":"In vitro GEF activity assay; co-immunoprecipitation of Sos1/Grb2/Eps8/E3b1; domain-mapping with CH2 mutants; Rac1 activation assay (GST-PBD pulldown)","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro GEF assay plus reciprocal co-IP and domain mutagenesis; single lab with multiple orthogonal methods","pmids":["16520382"],"is_preprint":false},{"year":2010,"finding":"Rac1 binds the adaptor protein caveolin-1 (Cav1); Rac1 activity promotes Cav1 accumulation at peripheral adhesions; Cav1 controls Rac1 protein levels by regulating ubiquitylation and proteasomal degradation of activated (GTP-bound) Rac1 in an adhesion-dependent manner, providing a non-canonical mechanism to terminate Rac1 signaling.","method":"Co-immunoprecipitation; Cav1-KO fibroblasts; siRNA/shRNA depletion; ubiquitylation assay; effector-binding assay with ubiquitylation-deficient Rac1 mutant","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, KO cells, ubiquitylation assay, and effector-binding controls in a single study; single lab with multiple orthogonal methods","pmids":["20460433"],"is_preprint":false},{"year":2017,"finding":"Rac1 partitions into nanoclusters of 50–100 molecules at the plasma membrane through interaction of its polybasic tail with PIP2 and PIP3; additional interactions with GEFs, GAPs, and effectors enrich nanoclusters in protruding regions, generating spatial gradients of Rac1 signaling nanodomains.","method":"Single-molecule imaging (SPT); super-resolution microscopy (PALM/STORM); pharmacological lipid perturbation","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — super-resolution and single-molecule imaging with lipid-interaction mechanistic testing; single lab","pmids":["29141223"],"is_preprint":false},{"year":2018,"finding":"Cdc42 and Rac1 gradients during cell migration are set by spatial patterns of GEFs and GAPs, not by transport; Rac1 gradient shaping specifically requires the GAP β2-chimaerin, which is localized to the cell tip through feedbacks from both Cdc42 and Rac1; the spatial extent of the Rac1 gradient controls cell migration speed.","method":"Optogenetics (light-controlled GEF recruitment); micropatterning; FRET biosensor imaging; β2-chimaerin KO/depletion","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — optogenetic perturbation combined with biosensor imaging and genetic KO; multiple orthogonal approaches in a single study","pmids":["30446664"],"is_preprint":false},{"year":2007,"finding":"Rac1 and Cdc42 use partially overlapping but distinct binding interfaces on IQGAP1: switch II residues Asp-63, Arg-68, and Leu-70 are critical for Rac1–IQGAP1 binding but not for Cdc42–IQGAP1 binding; residues 32 and 36 in switch I affect both; the Rho insert loop does not contribute; IQGAP1 and RhoGAP binding sites on Rac1 overlap only partially.","method":"Site-directed mutagenesis of Rac1 and Cdc42; binding affinity measurements (ITC/fluorescence); competition assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with quantitative binding measurements; multiple mutants tested in parallel for two GTPases","pmids":["17984089"],"is_preprint":false},{"year":2005,"finding":"Yersinia pseudotuberculosis YopE RhoGAP inactivates the membrane-associated pool of Rac1 globally, while YopT protease removes Rac1's membrane-targeting motif, releasing activated Rac1 into the cytoplasm/nucleus where it interacts with nuclear GEFs; the two effectors compete for membrane-associated Rac1, producing two spatially distinct pools with different activation states.","method":"FRET-based Rac1 activation biosensor imaging in living cells; bacterial infection with YopE and YopT mutant strains","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live FRET imaging with genetic bacterial mutant strains; single lab","pmids":["16228016"],"is_preprint":false},{"year":2004,"finding":"DGKγ (diacylglycerol kinase gamma) acts as an upstream suppressor of Rac1 via its catalytic activity; kinase-dead DGKγ (dominant-negative) selectively activates Rac1 (not Cdc42) and induces lamellipodia, while constitutively active DGKγ suppresses PDGF-induced lamellipodia; endogenous DGKγ co-immunoprecipitates with Rac1; dominant-negative Rac1 blocks lamellipodia induced by kinase-dead DGKγ, placing DGKγ upstream of Rac1.","method":"Expression of kinase-dead and constitutively active DGKγ mutants; co-immunoprecipitation; dominant-negative Rac1 epistasis; Rac1 activation assay (GST-PBD pulldown); confocal co-localization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis with dominant-negative plus co-IP and activation assay; single lab with multiple orthogonal approaches","pmids":["15102830"],"is_preprint":false},{"year":2011,"finding":"S6K1 acts upstream of Rac1 during platelet activation on fibrinogen; S6K1 and Rac1 interact in a protein complex with the Rac1 GEF TIAM1 and co-localize with actin at the platelet lamellipodial edge; mTOR inhibitors block Rac1 activation and platelet spreading without affecting Src or FAK, placing mTOR–S6K1 upstream of Rac1 in this pathway.","method":"Co-immunoprecipitation (S6K1–Rac1–TIAM1 complex); pharmacological inhibition of S6K1, mTOR, Src, FAK; Rac1 activation assay; platelet spreading assay under shear flow","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP of tricomplex plus pharmacological epistasis; single lab","pmids":["21757621"],"is_preprint":false},{"year":2006,"finding":"DOCK2 associates with CrkL (via two separate DOCK2 regions binding the CrkL SH3 domain) in hematopoietic cells; a DOCK2-dCS mutant that cannot bind CrkL significantly inhibits CrkL-induced Rac1 activation; DOCK2 also associates with the Rac1 GEF Vav in Jurkat cells, placing DOCK2 in a CrkL–DOCK2–Vav complex upstream of Rac1.","method":"Co-immunoprecipitation (in vivo and in vitro); GST pulldown; Rac1 activation assay; immunocytochemistry","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with domain mapping and Rac1 activation assay; single lab","pmids":["12393632"],"is_preprint":false},{"year":2012,"finding":"Rac1 forms a nuclear complex with the GEF Tiam1 and the transcription factor RORγt in Th17 cells; this complex binds and activates the Il17a promoter; deletion of Rac1 in T cells more potently reduces IL-17A expression and EAE than Tiam1 deficiency alone.","method":"Co-immunoprecipitation of Tiam1/Rac1/RORγt complex; ChIP at the Il17 promoter; T-cell-specific Rac1 KO mice; EAE model; pharmacological Rac1 inhibition","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — nuclear complex demonstrated by co-IP plus ChIP; genetic KO plus pharmacological inhibition with defined transcriptional and in vivo phenotype","pmids":["27725632"],"is_preprint":false},{"year":2012,"finding":"Schwann cell myelination requires Rac1; Rac1 KO abrogates PAK phosphorylation and reduces NF2/merlin phosphorylation; NF2/merlin mutation rescues myelin deficits in Rac1-CKO mice; cAMP levels are reduced in Rac1-CKO SCs and elevation of cAMP restores myelination, placing NF2/merlin and cAMP downstream of Rac1 in a myelination pathway.","method":"Conditional Rac1 KO in Schwann cells; immunoblot for phospho-PAK and phospho-merlin; genetic rescue with NF2/merlin mutant in vivo; rolipram (cAMP elevation) pharmacological rescue in vivo","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with in vivo genetic and pharmacological rescue; multiple orthogonal pathway readouts","pmids":["23197717"],"is_preprint":false},{"year":2001,"finding":"Constitutively active Rac1-V12 inhibits anoikis (suspension-induced apoptosis) in MDCK epithelial cells by reducing caspase activity and DNA fragmentation; Rac1-mediated survival depends on PI3K activity; ERK, p38, and NF-κB pathways are activated by Rac1-V12 but are largely dispensable for the survival effect.","method":"Expression of Rac1-V12 in MDCK cells in suspension; caspase assay; DNA fragmentation; pharmacological inhibition of PI3K, ERK, p38, NF-κB","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function plus pharmacological pathway dissection with multiple readouts; single lab","pmids":["11369774"],"is_preprint":false},{"year":2009,"finding":"CCK activates Rac1 in pancreatic acini through Gα13 and Gαq acting cooperatively (but not Gαs or Gαi); RGS-2 (Gαq inhibitor) and p115-RGS (Gα12/13 inhibitor) both abolish CCK-induced Rac1 activation via a PLC-independent pathway; RhoA is activated exclusively through Gα13.","method":"Active Gα expression constructs; Rac1/RhoA activation assays (pulldown); RGS domain inhibitors; RT-PCR and western for Gα13","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct GTPase activation assays with specific Gα inhibitory domains; single lab","pmids":["19940064"],"is_preprint":false},{"year":2008,"finding":"NOD2 stimulation activates Rac1 in human monocytes; β-PIX co-immunoprecipitates with NOD2 and Rac1 upon MDP stimulation; knockdown of β-PIX or Rac1 abrogates membrane recruitment of NOD2 and NOD2 interaction with its negative regulator Erbin, demonstrating that β-PIX–Rac1 mediate NOD2 trafficking and negative feedback regulation.","method":"Rac1 activation assay; co-immunoprecipitation of NOD2–β-PIX–Rac1; siRNA knockdown; immunofluorescence for NOD2 membrane localization; IL-8/NF-κB reporter","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus siRNA with membrane localization and functional output; single lab","pmids":["18684957"],"is_preprint":false},{"year":2006,"finding":"Integrin-linked kinase (ILK) activates Rac1 via β-PIX; ILK associates with PKL and the Rac1/Cdc42 GEF β-PIX; dominant-negative β-PIX reverses ILK-induced Rac1 activation; ILK knockdown reduces active Rac1 levels, placing β-PIX downstream of ILK and upstream of Rac1 in integrin-mediated cell spreading.","method":"Co-immunoprecipitation of ILK–PKL–β-PIX; Rac1 activation assay (GST-PBD pulldown); siRNA knockdown; dominant-negative β-PIX epistasis; ILK-GFP-F overexpression","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP of complex plus epistasis with dominant-negative and siRNA; single lab","pmids":["16723384"],"is_preprint":false},{"year":2013,"finding":"GluN3A-containing NMDA receptors bind GIT1, limiting GIT1 synaptic localization and its ability to complex β-PIX, thereby decreasing Rac1 activation and PAK phosphorylation in spines and reducing spine density/size; knockdown of GluN3A increases GIT1/β-PIX complex formation and Rac1/PAK activation. GluN3A–GIT1 binding is regulated by synaptic activity.","method":"Co-immunoprecipitation of GluN3A–GIT1; Rac1 activation assay; GluN3A KO mice; shRNA knockdown; immunofluorescence; PAK phosphorylation immunoblot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, KO mice, shRNA loss-of-function with multiple orthogonal biochemical and morphological readouts","pmids":["24297929"],"is_preprint":false},{"year":2014,"finding":"Rac1 contains a redox-sensitive cysteine (Cys18) with a lowered pKa; oxidation of Cys18 by glutathione (glutathiolation) greatly perturbs guanine nucleotide binding and promotes nucleotide exchange, activating Rac1; Rac1 is glutathiolated in primary chondrocytes; the C18D mimetic mutant shows enhanced GTP-loading and promotes lamellipodia formation in cells.","method":"Mass spectrometry identification of glutathiolation; in vitro nucleotide-exchange assay with oxidized Rac1; pKa measurement; C18D/C18S mutagenesis; GTP-bound Rac1 pulldown in cells; lamellipodia formation assay","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution with mutagenesis plus cell-based validation; multiple orthogonal methods in a single rigorous study","pmids":["25289457"],"is_preprint":false},{"year":2006,"finding":"Alsin, a GEF for Rac1 (and Rab5), supports motoneuron survival and axon growth through Rac1 signaling; alsin knockdown–induced cell death and reduced axon growth are mimicked by dominant-negative Rac1 and fully rescued by constitutively active Rac1, while dominant-negative/active Rab5 has no such effect.","method":"siRNA knockdown of alsin in embryonic rat spinal motoneurons; expression of dominant-negative and constitutively active Rac1 and Rab5; cell survival counting; axon length measurement","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis via gain- and loss-of-function with isoform-specific controls; single lab","pmids":["16802292"],"is_preprint":false},{"year":2006,"finding":"Loss or gain of Rac1 activity induces premature senescence in primary MEFs through increased reactive oxygen species (ROS) production and p53 activation (phospho-Ser15); ROS inhibitor blocks DNA damage foci formation; genetic p53 deletion reverses senescence in both Rac1−/− and L61Rac1 cells, placing ROS-mediated genomic instability and p53 upstream of Rac1-regulated senescence.","method":"Rac1 gene-targeted MEFs; constitutively active L61Rac1; ROS measurement; TUNEL; phospho-H2AX foci; p53 phosphorylation; p53 genetic deletion epistasis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus gain-of-function with p53 epistasis; single lab with multiple readouts","pmids":["17032649"],"is_preprint":false},{"year":2019,"finding":"Non-prenylated Rac1 has high affinity for IQGAP1, which facilitates both GTP exchange and ubiquitination-mediated degradation of Rac1; inactivating IQGAP1 normalizes Rac1 GTP-loading and reduces inflammation; heterozygous Rac1 deletion (but not Rhoa or Cdc42) reverses arthritis in GGTase-I-deficient mice. Prenylation of Rac1 by GGTase-I therefore normally restrains Rac1 effector interactions.","method":"Rac1+/− genetic rescue in GGTase-I KO mice; IQGAP1 KO mice; co-immunoprecipitation and ubiquitination assays; Rac1 GTP-loading assay; inflammatory phenotype scoring","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic rescue experiments with two independent KOs plus biochemical mechanism; multiple orthogonal approaches","pmids":["31484924"],"is_preprint":false},{"year":2018,"finding":"CYRI (Fam49) binds activated Rac1 via its DUF1394 domain, locally suppresses Scar/WAVE recruitment at the cell edge, limits protrusion size and duration, and thereby regulates pseudopod polarity, chemotaxis, and epithelial polarization; CYRI-depleted cells show larger, longer-lived optogenetically induced pseudopods.","method":"Co-immunoprecipitation and biochemical binding assay (DUF1394–Rac1); CYRI KO/overexpression; optogenetic Rac1 activation; Scar/WAVE immunofluorescence; migration/chemotaxis assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding demonstrated biochemically plus KO/OE with optogenetic and functional assays; multiple orthogonal methods","pmids":["30054448"],"is_preprint":false},{"year":2019,"finding":"Transient immobilizations of activated Rac1 at the lamellipodium tip correlate with its activation and depend on effector binding including the WAVE regulatory complex (WRC); optogenetic Rac1 activation close to the lamellipodium tip (but not behind it) is required for efficient membrane protrusion; these data establish that short-lived Rac1 activation triggers WRC-dependent actin branching at the lamellipodium tip.","method":"Single-particle tracking (SPT); optogenetic Rac1 activation (Tiam1 membrane recruitment); Rac1 effector-loop mutants; WRC mutant cells; super-resolution imaging","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — optogenetics combined with SPT and effector-loop mutagenesis in a single mechanistic study","pmids":["31422887"],"is_preprint":false},{"year":2009,"finding":"Activated Rac1 (Rac(V12)) induces upregulation of IL-6 family cytokines, which activate gp130/Stat3 signaling; gp130 knockdown reduces Stat3 activity, cell migration, and proliferation induced by Rac(V12), identifying gp130/Stat3 as an essential effector pathway downstream of activated Rac1.","method":"Expression of Rac1(V12) in HC11 cells; gp130 siRNA knockdown; Stat3 luciferase reporter; IL-6 mRNA quantification; cell migration/proliferation assays","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function plus siRNA epistasis with multiple readouts; single lab","pmids":["19852956"],"is_preprint":false},{"year":2009,"finding":"Rac1 signaling inhibits the transcriptional repressor BCL-6; active Rac1 mutants cause BCL-6 to lose nuclear dot localization and become non-chromatin-bound, inducing expression of BCL-6 target genes NF-κB1/p105 and CD44; PAK1 mediates this inhibition downstream of Rac1 and can directly phosphorylate BCL-6; notably, the splice variant Rac1b does not stimulate these effects.","method":"Active Rac1 mutant transfection; NSC23766 pharmacological inhibition; luciferase reporter; fractionation/immunofluorescence for BCL-6; in vitro PAK1 kinase assay with BCL-6 substrate","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay for PAK1→BCL-6 plus cell-based gain/loss-of-function with fractionation; single lab","pmids":["19487462"],"is_preprint":false},{"year":2011,"finding":"Rac1 is sequentially activated downstream of Rap1/CalDAG-GEFI via GPVI in platelets; Rac1 in turn provides positive feedback for both CalDAG-GEFI- and P2Y12-dependent Rap1 activation via calcium mobilization and granule/ADP release; Rac1 controls lamellipodia formation, clot retraction, and granule release; two pools of Rac1 exist, one directly downstream of GPVI and one downstream of Rap1.","method":"Rac1 inhibitor EHT 1864 in platelets; CalDAG-GEFI/P2Y12 double KO mice; Rac1 activation assay; platelet spreading; calcium flux; clot retraction assay","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological plus genetic KO approaches with multiple platelet function readouts; single lab","pmids":["22075250"],"is_preprint":false},{"year":2012,"finding":"Wnt3a stimulation activates Rac1 by promoting CK1-dependent phosphorylation of p120-catenin, enabling its release from E-cadherin and binding to the Rac1 GEF Vav2 and Rac1 itself; this trimeric p120-catenin/Vav2/Rac1 complex facilitates Rac1 activation; p120-catenin mutants defective in E-cadherin release or Vav2/Rac1 binding cannot rescue p120-catenin depletion in Xenopus gastrulation.","method":"Co-immunoprecipitation of p120-catenin/Vav2/Rac1; Rac1 activation assay; Src/Fyn and CK1 phosphorylation; Xenopus depletion/rescue assays","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with phosphorylation dissection plus in vivo Xenopus rescue; single lab","pmids":["22946057"],"is_preprint":false},{"year":2020,"finding":"PKCα positively regulates Rac1 activation during single-spine structural plasticity in neurons; removal of PKCα from the postsynapse attenuates Rac1 (but not Ras or Cdc42) activation; disruption of PKCα's PDZ binding domain impairs both Rac1 activation and structural spine remodeling.","method":"Two-photon uncaging; FRET biosensors for Rac1, Cdc42, Ras in single spines; PKCα shRNA knockdown; PDZ-domain PKCα mutant","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-spine biosensor imaging with loss-of-function and domain mutant; single lab","pmids":["32019972"],"is_preprint":false},{"year":2020,"finding":"NGF triggers prenylation (geranylgeranylation) of newly synthesized Rac1 in sympathetic axons in a local protein-synthesis-dependent manner; newly prenylated Rac1 localizes to TrkA-harboring endosomes in axons and promotes receptor trafficking necessary for axon growth; conditional KO of prenylation machinery abolishes sympathetic axon target innervation.","method":"Conditional KO of geranylgeranyltransferase in sympathetic neurons; axonal compartment isolation; prenylation assay in isolated axons; TrkA endosome co-localization; axon growth assays","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO plus compartmentalized biochemistry and imaging with multiple mechanistic readouts; single rigorous study","pmids":["32533921"],"is_preprint":false},{"year":1994,"finding":"Expression of α1-chimaerin (a Rac1-specific GAP) in NIH3T3 fibroblasts reduces Rac1 activity (confirmed by in-extract GAP assay) and impairs actin stress fiber formation, focal adhesion assembly (vinculin clusters), and integrin-mediated adhesion to fibronectin following growth factor stimulation, establishing that GAP-mediated inactivation of Rac1 negatively regulates actin cytoskeletal organization.","method":"Stable transfection of α1-chimaerin; in-extract Rac1 GAP activity assay (regulated by phosphatidylserine/phorbol ester); actin/vinculin immunofluorescence; fibronectin adhesion assay","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in-extract GAP activity assay plus cell-based loss-of-function phenotype; single lab","pmids":["7534315"],"is_preprint":false},{"year":2011,"finding":"Rac1 and calmodulin (CaM) interact with high binding affinity through the Rac1 polybasic region and its prenyl group; CaM inhibition inactivates Rac1, increases Rac1–PIP5K interaction, and induces extensive PI4,5P2-positive tubular plasma-membrane invaginations via an ARF6-dependent clathrin-independent endocytic pathway; inactive Rac1 mutant expression enhances tubulation by recruiting PIP5K, while active Rac1 impairs it.","method":"Binding affinity measurements (Rac1–CaM); CaM inhibitor treatment; constitutively active/inactive Rac1 mutant expression; PI4,5P2 immunofluorescence; endocytosis assays","journal":"Traffic","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assay plus gain/loss-of-function with endocytic phenotype; single lab","pmids":["21883766"],"is_preprint":false},{"year":2020,"finding":"IQGAP1 mediates sustained VEGF-induced Rac1 activation in choroidal endothelial cells via VEGFR2–Src–Rac1 signaling; IQGAP1 binding to Rac1-GTP sustains Rac1 activation; an IQGAP1 construct unable to bind Rac1 abolishes sustained Rac1 activation; Iqgap1−/− mice have reduced Rac1-GTP and choroidal neovascularization.","method":"IQGAP1 KO mice; IQGAP1-Rac1 binding-deficient mutant; Rac1-GTP pulldown; Src/VEGFR2 inhibition; CEC migration and tube formation assays; laser-induced CNV model","journal":"Angiogenesis","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mice plus domain-mutant rescue with multiple biochemical and in vivo readouts; multiple orthogonal methods","pmids":["32783108"],"is_preprint":false},{"year":2022,"finding":"Smo activation by Hh ligand leads to Smo binding Vav2, increased Vav2 phosphorylation at Y172, and consequent Rac1 activation; active Rac1 then phosphorylates KIF3A at S689/T694, stabilizes IFT88, and dampens SuFu–Gli complex formation, enabling Gli nuclear translocation and Hh target gene expression; Rac1 deficiency in mouse limb bud ectoderm impedes Gli nuclear translocation.","method":"Co-immunoprecipitation of Smo–Vav2; Vav2 phosphorylation assay; Rac1 activation assay; KIF3A phosphorylation; IFT88 stability; SuFu–Gli co-IP; Rac1 conditional KO mouse; human MB tissue analysis","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple co-IPs and KO mouse with defined transcriptional readout; single lab with multiple molecular steps characterized","pmids":["35154488"],"is_preprint":false},{"year":2018,"finding":"Thrombospondin–α2δ-1 interaction promotes synaptogenesis postsynaptically via Rac1; postsynaptic (but not presynaptic) α2δ-1 is required and sufficient for TSP-induced synaptogenesis and spine formation in vivo; an autism-linked α2δ-1 mutant cannot rescue these defects.","method":"Cell-type-specific KO of α2δ-1; TSP-induced synaptogenesis assay; Rac1 activation assay; electron microscopy; in vivo spine counting","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-specific KO with Rac1 activation assay and multiple synapse readouts; single lab","pmids":["30054448"],"is_preprint":false}],"current_model":"RAC1 is a Rho-family small GTPase that cycles between GDP-bound (inactive) and GTP-bound (active) states under control of GEFs (including Tiam1, Vav, Sos1, DOCK2/Vav, Vav2/p120-catenin, alsin), GAPs (including α1-chimaerin, CYK4/centralspindlin, SptP, β2-chimaerin), RhoGDI, ubiquitin-dependent degradation (promoted by caveolin-1), and post-translational modifications including geranylgeranylation (which restrains effector interactions), glutathiolation of Cys18 (which promotes nucleotide exchange), and PAK-dependent phosphorylation; once GTP-loaded, active Rac1 immobilizes in nanoclusters at the plasma membrane through its polybasic tail interacting with PIP2/PIP3, and at the lamellipodium tip interacts with the WAVE regulatory complex (WRC/Scar) to drive actin branching and membrane protrusion, while additional effectors including IQGAP1 (which scaffolds Rac1 with CLIP-170 to capture microtubule plus-ends for cell polarization), PAK1/2 (downstream of which BCL-6 repression, NF-κB activation, and stem-cell c-Myc regulation are mediated), PI3K, and the gp130/Stat3 axis link Rac1 to cell survival, proliferation, transcription (including Il17a via a nuclear Tiam1/Rac1/RORγt complex), NADPH oxidase activation (through gp91phox/p67phox interaction), and organelle-specific functions including ARF6-dependent endocytosis modulated by calmodulin, mitochondrial dynamics, and TrkA endosome trafficking in axons."},"narrative":{"mechanistic_narrative":"RAC1 is a Rho-family small GTPase that cycles between GDP-bound and GTP-bound states to orchestrate actin-dependent membrane remodeling, cell polarity, migration, survival, and lineage-specific transcriptional programs [PMID:10934035, PMID:29141223, PMID:31422887]. Its activity is set spatially: GTP-loaded Rac1 partitions into plasma-membrane nanoclusters through its polybasic tail engaging PIP2/PIP3 [PMID:29141223], and transient effector-dependent immobilizations at the lamellipodium tip drive WAVE regulatory complex (WRC)-dependent actin branching and membrane protrusion, a process locally restrained by the Rac1-binding suppressor CYRI/Fam49, which limits Scar/WAVE recruitment [PMID:30054448, PMID:31422887]. Active Rac1 also captures microtubule plus-ends for polarization by forming a Rac1–IQGAP1–CLIP-170 complex, and IQGAP1 binding both sustains GTP-loading and, for non-prenylated Rac1, routes it to ubiquitin-dependent degradation [PMID:12110184, PMID:17984089, PMID:31484924, PMID:32783108]. Rac1 activity is controlled by GEFs (Sos1, Vav/Vav2, DOCK2, alsin, Tiam1, β-PIX), GAPs (α1-/β2-chimaerin, centralspindlin CYK4, bacterial SptP and YopE), caveolin-1-promoted ubiquitin-dependent degradation, geranylgeranylation that restrains effector engagement, and Cys18 glutathiolation that promotes nucleotide exchange [PMID:10499590, PMID:22945935, PMID:16520382, PMID:30446664, PMID:12393632, PMID:25289457, PMID:16802292, PMID:31484924, PMID:7534315]. Downstream, Rac1 engages PAK to regulate c-Myc-dependent epidermal stem cell fate, controls NADPH oxidase by promoting gp91phox–p67phox assembly, supports PI3K-dependent survival/anoikis resistance, and acts in the nucleus with Tiam1 and RORγt to activate the Il17a promoter [PMID:16081735, PMID:16651530, PMID:27725632, PMID:11369774]. Genetic studies establish non-redundant, isoform-specific roles in hematopoietic stem cell engraftment, Schwann cell myelination, chondrogenesis, axon growth, synaptic plasticity, and cardiac hypertrophy [PMID:14564009, PMID:16081735, PMID:16651530, PMID:23197717, PMID:32533921]. Beyond these characterized axes, the corpus does not establish a unifying structural model of Rac1 nanocluster assembly.","teleology":[{"year":1994,"claim":"Established that GAP-driven inactivation of Rac1 is a negative regulator of actin cytoskeletal architecture, defining the functional consequence of switching Rac1 off.","evidence":"Stable α1-chimaerin expression with in-extract Rac1 GAP assay and actin/vinculin/adhesion phenotyping in NIH3T3 cells","pmids":["7534315"],"confidence":"Medium","gaps":["Single GAP studied; spatial control of GAP action not addressed","Effectors linking Rac1 to stress fibers/adhesion not identified here"]},{"year":1996,"claim":"Placed Rac1 as an obligate effector linking the Vav GEF to the JNK/SAPK kinase cascade and oncogenic transformation, connecting Rac1 to stress-kinase signaling.","evidence":"Dominant-negative Rac1 N17 epistasis with JNK/SAPK kinase assay and focus formation in COS-7/NIH3T3","pmids":["8760286"],"confidence":"Medium","gaps":["Intermediate kinases between Rac1 and JNK not defined","Dominant-negative approach cannot exclude effects on related GTPases"]},{"year":1996,"claim":"Demonstrated conformation-specific Rac1 binding to tubulin requiring the active state but not GTP hydrolysis, an early link between Rac1 and the microtubule system.","evidence":"GTP-overlay binding, purified tubulin reconstitution, and effector-domain (D38A) plus GTPase-dead mutagenesis","pmids":["8631991"],"confidence":"High","gaps":["Cellular relevance of direct tubulin binding not established","Relationship to IQGAP1/CLIP-170 microtubule capture unresolved"]},{"year":1997,"claim":"Showed Rac1 is required for FcγR-mediated phagocytosis acting downstream of F-actin recruitment, distinguishing actin nucleation from membrane remodeling.","evidence":"Dominant-negative Rac1 N17 with F-actin staining and phagocytosis assays in macrophages","pmids":["9348306"],"confidence":"High","gaps":["Effectors mediating membrane remodeling not identified","Mechanism of cup closure unresolved"]},{"year":1998,"claim":"Refined the phagocytic role by showing Rac1 and Cdc42 perform distinct membrane/actin functions and coordinate phosphotyrosine resolution around particles.","evidence":"Stable dominant-negative Rac1/Cdc42 lines with morphology and phosphotyrosine imaging in RBL-2H3 mast cells","pmids":["9799231"],"confidence":"High","gaps":["Molecular basis of the Rac1-vs-Cdc42 morphological divergence not defined"]},{"year":1998,"claim":"Defined the Rac1 polybasic C-terminus as a GTP-independent docking site for lipid kinases, linking Rac1 to local phosphoinositide metabolism and RhoGDI handoff.","evidence":"In vitro binding with Rac1 chimeras/peptides, co-purification, and RhoGDI co-IP","pmids":["9447972"],"confidence":"High","gaps":["Functional output of the lipid-kinase complex on Rac1 signaling not tested","Single-lab biochemistry"]},{"year":1999,"claim":"Showed a bacterial effector (SptP) directly inactivates Rac1 as a GAP, providing biochemical proof that GTP hydrolysis reverses Rac1-driven cytoskeletal changes.","evidence":"In vitro GAP assay with purified SptP and Rac1/Cdc42 plus cellular phenotypic rescue","pmids":["10499590"],"confidence":"High","gaps":["Host GAP equivalents not addressed here"]},{"year":2000,"claim":"Established that membrane recruitment of active Rac1 alone suffices for actin polymerization and internalization, and that effector binding (F37 loop) is essential.","evidence":"Rapamycin-inducible membrane recruitment with effector-loop mutagenesis and bead internalization","pmids":["10934035"],"confidence":"High","gaps":["Identity of the essential effector not pinned down in this system"]},{"year":2001,"claim":"Identified PI3K as the survival-relevant branch downstream of active Rac1 in anoikis resistance, separating survival from ERK/p38/NF-κB outputs.","evidence":"Rac1-V12 expression in suspended MDCK cells with caspase/DNA-fragmentation readouts and pathway inhibitors","pmids":["11369774"],"confidence":"Medium","gaps":["Direct Rac1–PI3K link mechanism not shown","Gain-of-function only"]},{"year":2002,"claim":"Defined the Rac1/Cdc42–IQGAP1–CLIP-170 tripartite complex that captures microtubule plus-ends to establish a single leading edge, connecting Rac1 to polarity.","evidence":"Reciprocal co-IP, GFP live imaging, and IQGAP1 binding-mutant expression in fibroblasts","pmids":["12110184"],"confidence":"High","gaps":["How active Rac1 is spatially restricted to one edge not resolved here"]},{"year":2003,"claim":"Genetically resolved non-redundant Rac1-vs-Rac2 functions, assigning HSC/progenitor retention and engraftment to Rac1 and oxidase/migration to Rac2.","evidence":"Conditional single and double Rac1/Rac2 knockouts with transplantation, oxidase, and migration assays in mice","pmids":["14564009"],"confidence":"High","gaps":["Molecular basis of isoform specificity not defined"]},{"year":2005,"claim":"Placed Rac1 upstream of PAK2 and c-Myc in epidermal stem cell fate, showing Rac1 restrains stem-cell differentiation.","evidence":"Inducible epidermal Rac1 KO with BrdU, c-Myc/PAK2 staining and epistasis in mice","pmids":["16081735"],"confidence":"High","gaps":["Direct PAK2 substrate driving c-Myc regulation not identified"]},{"year":2005,"claim":"Showed Rac1/Cdc42 drive chondrocyte hypertrophy and apoptosis via p38 MAPK, antagonizing RhoA, linking Rac1 to skeletal cell-fate transitions.","evidence":"Gain-of-function plus p38 inhibitor epistasis with reporter, TUNEL, and phospho-p38 in chondrocytes","pmids":["15883643"],"confidence":"Medium","gaps":["Endogenous Rac1 requirement not genetically tested here","Single lab"]},{"year":2005,"claim":"Demonstrated bacterial YopE/YopT generate spatially distinct Rac1 pools, revealing membrane vs cytoplasmic/nuclear Rac1 activation states.","evidence":"FRET Rac1 biosensor imaging during infection with YopE/YopT mutant Yersinia","pmids":["16228016"],"confidence":"Medium","gaps":["Nuclear Rac1 GEFs not identified","Single-lab live-imaging study"]},{"year":2006,"claim":"Connected Rac1 to cardiac NADPH oxidase by showing Rac1 is required for gp91phox–p67phox assembly and angiotensin-II-induced hypertrophy.","evidence":"Cardiomyocyte-specific Rac1 KO with oxidase co-IP, activity, ROS, and echocardiography","pmids":["16651530"],"confidence":"High","gaps":["Direct Rac1 contact within the oxidase complex not mapped here"]},{"year":2006,"claim":"Defined a p66shc–Sos1–Eps8–E3b1 module that enhances Rac1-specific GEF activity and oxidative stress, linking Rac1 activation to redox signaling.","evidence":"In vitro GEF assay, reciprocal co-IP, CH2 domain mapping, and Rac1-GTP pulldown","pmids":["16520382"],"confidence":"High","gaps":["Physiological trigger of this module not defined here"]},{"year":2006,"claim":"Identified DGKγ as an upstream catalytic suppressor of Rac1 controlling lamellipodia, expanding lipid control of Rac1.","evidence":"DGKγ kinase-dead/active mutants, co-IP, dominant-negative Rac1 epistasis, and activation assays","pmids":["15102830"],"confidence":"Medium","gaps":["GEF/GAP intermediary between DGKγ and Rac1 not defined","Single lab"]},{"year":2006,"claim":"Established alsin as a Rac1 GEF supporting motoneuron survival and axon growth, with Rac1 (not Rab5) as the relevant effector.","evidence":"Alsin siRNA with dominant-negative/active Rac1 and Rab5 rescue in motoneurons","pmids":["16802292"],"confidence":"Medium","gaps":["Downstream survival effectors not identified","Single lab"]},{"year":2006,"claim":"Showed both loss and gain of Rac1 activity drive premature senescence via ROS and p53, identifying a homeostatic Rac1 activity window.","evidence":"Rac1-targeted and L61Rac1 MEFs with ROS, γH2AX, p53 phosphorylation, and p53-deletion epistasis","pmids":["17032649"],"confidence":"Medium","gaps":["ROS source linking Rac1 to p53 not defined here","Single lab"]},{"year":2006,"claim":"Placed β-PIX downstream of ILK and upstream of Rac1 in integrin-mediated spreading, defining an adhesion-coupled activation route.","evidence":"ILK–PKL–β-PIX co-IP, dominant-negative β-PIX and siRNA epistasis, Rac1-GTP pulldown","pmids":["16723384"],"confidence":"Medium","gaps":["Direct β-PIX nucleotide exchange on Rac1 not isolated here","Single lab"]},{"year":2007,"claim":"Mapped Rac1 switch-region determinants (Asp63/Arg68/Leu70, residues 32/36) that distinguish IQGAP1 binding from Cdc42 and partially overlap GAP sites.","evidence":"Systematic Rac1/Cdc42 mutagenesis with quantitative binding and competition assays","pmids":["17984089"],"confidence":"High","gaps":["In-cell consequences of selective interface mutations not tested here"]},{"year":2007,"claim":"Showed Rac1 promotes chondrogenesis and N-cadherin/Sox9 expression, extending its role to mesenchymal differentiation.","evidence":"Pharmacologic inhibition, dominant-active overexpression, and conditional KO micromass cultures with RT-PCR/immunoblot","pmids":["17573353"],"confidence":"Medium","gaps":["Effector pathway from Rac1 to Sox9 not defined","Single lab"]},{"year":2008,"claim":"Identified a β-PIX–Rac1 module mediating NOD2 membrane trafficking and negative feedback via Erbin in innate immune signaling.","evidence":"Rac1 activation assay, NOD2–β-PIX–Rac1 co-IP, siRNA, and NOD2 localization/NF-κB readouts","pmids":["18684957"],"confidence":"Medium","gaps":["Whether Rac1 GTP-loading is required vs scaffolding not separated","Single lab"]},{"year":2009,"claim":"Defined gp130/Stat3 as an essential effector axis downstream of active Rac1 driving migration and proliferation.","evidence":"Rac1-V12 expression with gp130 siRNA, Stat3 reporter, and proliferation/migration assays","pmids":["19852956"],"confidence":"Medium","gaps":["Mechanism of Rac1-induced IL-6 upregulation not defined","Gain-of-function only"]},{"year":2009,"claim":"Linked Rac1 to transcriptional derepression by showing PAK1 phosphorylates and inactivates BCL-6, with isoform-selective behavior of Rac1 vs Rac1b.","evidence":"Active Rac1 mutants, NSC23766 inhibition, BCL-6 fractionation, and in vitro PAK1 kinase assay on BCL-6","pmids":["19487462"],"confidence":"Medium","gaps":["Endogenous physiological context of BCL-6 regulation not tested","Single lab"]},{"year":2009,"claim":"Showed CCK activates Rac1 through cooperative Gα13/Gαq signaling independent of PLC, defining a GPCR route to Rac1 in acinar cells.","evidence":"Active Gα constructs, RGS inhibitors, and Rac1/RhoA activation assays","pmids":["19940064"],"confidence":"Medium","gaps":["GEF coupling Gα proteins to Rac1 not identified","Single lab"]},{"year":2010,"claim":"Revealed a non-canonical termination mechanism in which caveolin-1 directs ubiquitin-proteasomal degradation of GTP-bound Rac1 in an adhesion-dependent manner.","evidence":"Cav1 co-IP, Cav1-KO fibroblasts, ubiquitylation assay, and ubiquitylation-deficient Rac1 mutant","pmids":["20460433"],"confidence":"High","gaps":["E3 ligase responsible for Rac1 ubiquitylation not identified here"]},{"year":2011,"claim":"Demonstrated high-affinity Rac1–calmodulin binding via the polybasic/prenyl region controls ARF6-dependent clathrin-independent endocytosis and PIP5K recruitment.","evidence":"Binding measurements, CaM inhibition, active/inactive Rac1 mutants, and PI4,5P2 tubulation/endocytosis assays","pmids":["21883766"],"confidence":"Medium","gaps":["Physiological cargo of this endocytic route not defined","Single lab"]},{"year":2011,"claim":"Placed mTOR–S6K1 upstream of Rac1 in platelet spreading via an S6K1–Rac1–TIAM1 complex independent of Src/FAK.","evidence":"Co-IP of the tricomplex with mTOR/S6K1/Src/FAK inhibitor epistasis and spreading assays","pmids":["21757621"],"confidence":"Medium","gaps":["Whether S6K1 acts catalytically on the GEF not resolved","Single lab"]},{"year":2011,"claim":"Resolved sequential Rap1→Rac1 signaling with Rac1 positive feedback onto Rap1, defining two Rac1 pools in platelet activation.","evidence":"EHT1864 inhibition, CalDAG-GEFI/P2Y12 double-KO mice, activation assays, and clot retraction","pmids":["22075250"],"confidence":"Medium","gaps":["GEFs defining the two Rac1 pools not separately identified","Single lab"]},{"year":2012,"claim":"Established CYK4/centralspindlin as a Rac1-specific GAP that spatially segregates adhesion (ARHGEF7/PAK1) from the contractile ring during cytokinesis.","evidence":"In vitro GAP assay, GAP-mutant expression, and ARHGEF7/PAK1 depletion rescue with cytokinesis phenotyping","pmids":["22945935"],"confidence":"High","gaps":["How CYK4 GAP activity is spatially confined to the equator not fully resolved"]},{"year":2012,"claim":"Identified a nuclear Tiam1/Rac1/RORγt complex that activates the Il17a promoter, giving Rac1 a direct transcriptional role in Th17 immunity.","evidence":"Co-IP, ChIP at Il17, T-cell-specific Rac1 KO, EAE model, and pharmacologic inhibition","pmids":["27725632"],"confidence":"High","gaps":["How nuclear Rac1 is recruited/retained not defined"]},{"year":2012,"claim":"Showed Wnt3a activates Rac1 through CK1-dependent p120-catenin release from E-cadherin enabling a p120/Vav2/Rac1 complex, linking cadherin junctions to Rac1.","evidence":"Co-IP of p120/Vav2/Rac1, phosphorylation dissection, and Xenopus depletion/rescue","pmids":["22946057"],"confidence":"Medium","gaps":["Direct catalytic step of Vav2 on Rac1 in this complex not isolated","Single lab"]},{"year":2012,"claim":"Demonstrated Rac1 is required for Schwann cell myelination acting upstream of PAK, NF2/merlin, and cAMP, with genetic and pharmacologic rescue.","evidence":"Conditional Rac1 KO, phospho-PAK/merlin immunoblots, NF2 mutant rescue, and rolipram rescue in mice","pmids":["23197717"],"confidence":"High","gaps":["How Rac1 lowers cAMP mechanistically not defined"]},{"year":2013,"claim":"Showed GluN3A-NMDARs sequester GIT1 to limit β-PIX/Rac1/PAK signaling and spine growth, an activity-regulated brake on Rac1 in synapses.","evidence":"GluN3A–GIT1 co-IP, KO mice, shRNA, Rac1 activation assay, and spine morphology","pmids":["24297929"],"confidence":"High","gaps":["Structural basis of GluN3A–GIT1 competition with β-PIX not defined"]},{"year":2014,"claim":"Identified Cys18 glutathiolation as a redox switch that promotes Rac1 nucleotide exchange and activation, linking oxidative state to GTP-loading.","evidence":"Mass spectrometry, in vitro nucleotide exchange on oxidized Rac1, pKa measurement, and C18 mutants with cellular validation","pmids":["25289457"],"confidence":"High","gaps":["Physiological oxidant source for endogenous Cys18 modification not pinned"]},{"year":2017,"claim":"Defined Rac1 plasma-membrane nanoclusters formed via polybasic-tail/PIP2-PIP3 binding and enriched in protrusions, establishing spatial nanodomain organization of Rac1 signaling.","evidence":"Single-molecule tracking and super-resolution imaging with lipid perturbation","pmids":["29141223"],"confidence":"Medium","gaps":["Compositional census of nanocluster effectors incomplete","Single lab"]},{"year":2018,"claim":"Showed Rac1 spatial gradients are shaped by localized GEF/GAP activity—specifically β2-chimaerin at the tip—rather than transport, controlling migration speed.","evidence":"Optogenetic GEF recruitment, FRET biosensors, micropatterning, and β2-chimaerin KO/depletion","pmids":["30446664"],"confidence":"High","gaps":["Feedback wiring localizing β2-chimaerin not fully resolved molecularly"]},{"year":2018,"claim":"Identified CYRI/Fam49 as a Rac1-binding suppressor of Scar/WAVE that limits protrusion size and tunes chemotaxis and polarity.","evidence":"DUF1394–Rac1 binding, CYRI KO/overexpression, optogenetic Rac1 activation, and Scar/WAVE imaging","pmids":["30054448"],"confidence":"High","gaps":["How CYRI competes with WRC at the molecular interface not fully mapped"]},{"year":2018,"claim":"Showed postsynaptic α2δ-1 is required and sufficient for thrombospondin-induced synaptogenesis via Rac1, linking a synaptogenic cue to Rac1.","evidence":"Cell-type-specific α2δ-1 KO, Rac1 activation assay, EM, and in vivo spine counts","pmids":["30054448"],"confidence":"Medium","gaps":["GEF coupling α2δ-1 to Rac1 not identified","Single lab"]},{"year":2019,"claim":"Established that prenylation by GGTase-I restrains Rac1, with non-prenylated Rac1 binding IQGAP1 to drive exchange and degradation and to fuel inflammation.","evidence":"Rac1+/- and IQGAP1 KO genetic rescue in GGTase-I-deficient mice with co-IP/ubiquitination and GTP-loading assays","pmids":["31484924"],"confidence":"High","gaps":["E3 ligase for non-prenylated Rac1 not identified"]},{"year":2019,"claim":"Demonstrated that short-lived, effector-dependent Rac1 immobilizations at the lamellipodium tip trigger WRC-dependent actin branching needed for protrusion.","evidence":"Single-particle tracking, tip-localized optogenetic activation, and Rac1 effector-loop/WRC mutants","pmids":["31422887"],"confidence":"High","gaps":["Mechanism converting transient immobilization into sustained WRC output not fully defined"]},{"year":2020,"claim":"Showed PKCα selectively promotes Rac1 activation during single-spine structural plasticity via its PDZ-binding domain.","evidence":"Two-photon uncaging, single-spine FRET biosensors, PKCα shRNA, and PDZ mutant","pmids":["32019972"],"confidence":"Medium","gaps":["GEF/effector linking PKCα to Rac1 not defined","Single lab"]},{"year":2020,"claim":"Revealed local prenylation of newly synthesized Rac1 targets it to TrkA endosomes to drive axonal receptor trafficking and target innervation.","evidence":"Conditional GGTase KO in sympathetic neurons, compartmentalized prenylation assays, and TrkA endosome imaging","pmids":["32533921"],"confidence":"High","gaps":["Effectors mediating Rac1's endosomal trafficking role not identified"]},{"year":2020,"claim":"Showed IQGAP1 sustains VEGF-induced Rac1 activation via VEGFR2–Src to drive endothelial migration and choroidal neovascularization.","evidence":"IQGAP1 KO mice, Rac1-binding-deficient mutant, Rac1-GTP pulldown, and CNV model","pmids":["32783108"],"confidence":"High","gaps":["How IQGAP1 binding extends GTP-loading kinetically not fully resolved"]},{"year":2022,"claim":"Placed Rac1 within Hedgehog signaling, where Smo–Vav2-activated Rac1 phosphorylates KIF3A, stabilizes IFT88, and enables Gli nuclear translocation.","evidence":"Smo–Vav2 co-IP, Rac1 activation, KIF3A phosphorylation, IFT88 stability, SuFu–Gli co-IP, and Rac1 conditional KO mice","pmids":["35154488"],"confidence":"Medium","gaps":["Direct vs indirect Rac1 phosphorylation of KIF3A not separated","Single lab"]},{"year":null,"claim":"A unifying structural and quantitative model integrating Rac1's lipid-anchored nanocluster assembly, prenylation/glutathiolation switches, and the combinatorial GEF/GAP code that selects among its many effector and transcriptional outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No single model reconciles spatial nanodomain control with effector selection","E3 ligase(s) for ubiquitin-dependent Rac1 turnover not identified across contexts","Determinants of nuclear vs membrane Rac1 function not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[1,13,30,42]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[4,7,35,36]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,6]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[5,16,43]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,16,19,35,43]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[19,23,37]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,6,35]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[41,43]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,14,26,45]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,3,8,23,27]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[13]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[23,37,45]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,11,24,41,45]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,3,27,41,43]}],"complexes":["Rac1–IQGAP1–CLIP-170 complex","WAVE regulatory complex (WRC/Scar)","Tiam1/Rac1/RORγt nuclear complex","gp91phox/p67phox NADPH oxidase complex"],"partners":["IQGAP1","TIAM1","VAV2","PAK1","CYRI/FAM49","CAVEOLIN-1","CALMODULIN","Β-PIX"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P63000","full_name":"Ras-related C3 botulinum toxin substrate 1","aliases":["Cell migration-inducing gene 5 protein","Ras-like protein TC25","p21-Rac1"],"length_aa":192,"mass_kda":21.4,"function":"Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization, neurons adhesion, migration and differentiation, and growth-factor induced formation of membrane ruffles (PubMed:1643658, PubMed:22843693, PubMed:23512198, PubMed:28886345). Rac1 p21/rho GDI heterodimer is the active component of the cytosolic factor sigma 1, which is involved in stimulation of the NADPH oxidase activity in macrophages. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. Stimulates PKN2 kinase activity (PubMed:9121475). In concert with RAB7A, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts (PubMed:1643658). In podocytes, promotes nuclear shuttling of NR3C2; this modulation is required for a proper kidney functioning. Required for atypical chemokine receptor ACKR2-induced LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. In neurons, is involved in dendritic spine formation and synaptic plasticity (By similarity). In hippocampal neurons, involved in spine morphogenesis and synapse formation, through local activation at synapses by guanine nucleotide exchange factors (GEFs), such as ARHGEF6/ARHGEF7/PIX (PubMed:12695502). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3. In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in PAK1 activation and eventually F-actin stabilization (By similarity). Required for DSG3 translocation to cell-cell junctions, DSG3-mediated organization of cortical F-actin bundles and anchoring of actin at cell junctions; via interaction with DSG3 (PubMed:22796473). Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:38355798) Isoform B has an accelerated GEF-independent GDP/GTP exchange and an impaired GTP hydrolysis, which is restored partially by GTPase-activating proteins (PubMed:14625275). It is able to bind to the GTPase-binding domain of PAK but not full-length PAK in a GTP-dependent manner, suggesting that the insertion does not completely abolish effector interaction (PubMed:14625275)","subcellular_location":"Cell membrane; Melanosome; Cytoplasm; Cell projection, lamellipodium; Cell projection, dendrite; Synapse; Nucleus","url":"https://www.uniprot.org/uniprotkb/P63000/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/RAC1","classification":"Common Essential","n_dependent_lines":961,"n_total_lines":1208,"dependency_fraction":0.7955298013245033},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000136238","cell_line_id":"CID000607","localizations":[{"compartment":"membrane","grade":3},{"compartment":"cytoplasmic","grade":2},{"compartment":"nucleoplasm","grade":2},{"compartment":"nuclear_punctae","grade":1}],"interactors":[{"gene":"ARHGDIA","stoichiometry":10.0},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"IQGAP1","stoichiometry":0.2},{"gene":"RAP1GDS1","stoichiometry":0.2},{"gene":"COX5B","stoichiometry":0.2},{"gene":"CALM2;CALM1;CALM3","stoichiometry":0.2},{"gene":"COX6C","stoichiometry":0.2},{"gene":"ARHGDIG","stoichiometry":0.2},{"gene":"UHRF1BP1L","stoichiometry":0.2},{"gene":"COX4I1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000607","total_profiled":1310},"omim":[{"mim_id":"621448","title":"CYFIP-RELATED RAC1 INTERACTOR A; CYRIA","url":"https://www.omim.org/entry/621448"},{"mim_id":"621092","title":"IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 3; IQGAP3","url":"https://www.omim.org/entry/621092"},{"mim_id":"620997","title":"SEMAPHORIN 3G; SEMA3G","url":"https://www.omim.org/entry/620997"},{"mim_id":"620665","title":"PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G4B; PLEKHG4B","url":"https://www.omim.org/entry/620665"},{"mim_id":"620134","title":"PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G1; PLEKHG1","url":"https://www.omim.org/entry/620134"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RAC1"},"hgnc":{"alias_symbol":["TC-25","p21-Rac1","Rac-1"],"prev_symbol":[]},"alphafold":{"accession":"P63000","domains":[{"cath_id":"3.40.50.300","chopping":"1-176","consensus_level":"medium","plddt":96.637,"start":1,"end":176}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P63000","model_url":"https://alphafold.ebi.ac.uk/files/AF-P63000-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P63000-F1-predicted_aligned_error_v6.png","plddt_mean":93.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAC1","jax_strain_url":"https://www.jax.org/strain/search?query=RAC1"},"sequence":{"accession":"P63000","fasta_url":"https://rest.uniprot.org/uniprotkb/P63000.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P63000/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P63000"}},"corpus_meta":[{"pmid":"12110184","id":"PMC_12110184","title":"Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12110184","citation_count":503,"is_preprint":false},{"pmid":"10499590","id":"PMC_10499590","title":"A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10499590","citation_count":431,"is_preprint":false},{"pmid":"14564009","id":"PMC_14564009","title":"Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/14564009","citation_count":398,"is_preprint":false},{"pmid":"9348306","id":"PMC_9348306","title":"Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9348306","citation_count":343,"is_preprint":false},{"pmid":"19151919","id":"PMC_19151919","title":"Rac1 GTPase: a \"Rac\" of all trades.","date":"2009","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/19151919","citation_count":297,"is_preprint":false},{"pmid":"16651530","id":"PMC_16651530","title":"Requirement of Rac1 in the development of cardiac hypertrophy.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16651530","citation_count":240,"is_preprint":false},{"pmid":"16081735","id":"PMC_16081735","title":"Stem cell depletion through epidermal deletion of Rac1.","date":"2005","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16081735","citation_count":216,"is_preprint":false},{"pmid":"9799231","id":"PMC_9799231","title":"Fc receptor-mediated phagocytosis requires CDC42 and Rac1.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9799231","citation_count":199,"is_preprint":false},{"pmid":"16772332","id":"PMC_16772332","title":"Rac1 and Rac2 regulate macrophage morphology but are not essential for migration.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16772332","citation_count":156,"is_preprint":false},{"pmid":"8760286","id":"PMC_8760286","title":"Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8760286","citation_count":154,"is_preprint":false},{"pmid":"9447972","id":"PMC_9447972","title":"Characterization of a Rac1- and RhoGDI-associated lipid kinase signaling complex.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9447972","citation_count":135,"is_preprint":false},{"pmid":"30054448","id":"PMC_30054448","title":"Thrombospondin receptor α2δ-1 promotes synaptogenesis and spinogenesis via postsynaptic Rac1.","date":"2018","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30054448","citation_count":125,"is_preprint":false},{"pmid":"10934035","id":"PMC_10934035","title":"Membrane recruitment of Rac1 triggers phagocytosis.","date":"2000","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/10934035","citation_count":121,"is_preprint":false},{"pmid":"21757621","id":"PMC_21757621","title":"S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21757621","citation_count":112,"is_preprint":false},{"pmid":"8631991","id":"PMC_8631991","title":"The Ras-related GTPase Rac1 binds tubulin.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8631991","citation_count":112,"is_preprint":false},{"pmid":"17573353","id":"PMC_17573353","title":"Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation, and chondrogenesis.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17573353","citation_count":104,"is_preprint":false},{"pmid":"34079763","id":"PMC_34079763","title":"Rac1, A Potential Target for Tumor Therapy.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34079763","citation_count":98,"is_preprint":false},{"pmid":"15883643","id":"PMC_15883643","title":"Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis.","date":"2005","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/15883643","citation_count":90,"is_preprint":false},{"pmid":"22945935","id":"PMC_22945935","title":"CYK4 inhibits Rac1-dependent PAK1 and ARHGEF7 effector pathways during cytokinesis.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22945935","citation_count":90,"is_preprint":false},{"pmid":"19472214","id":"PMC_19472214","title":"Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown.","date":"2009","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19472214","citation_count":88,"is_preprint":false},{"pmid":"27533896","id":"PMC_27533896","title":"Rac1 and RhoA: Networks, loops and bistability.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/27533896","citation_count":87,"is_preprint":false},{"pmid":"27699663","id":"PMC_27699663","title":"Impact of point mutation P29S in RAC1 on tumorigenesis.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27699663","citation_count":82,"is_preprint":false},{"pmid":"34006303","id":"PMC_34006303","title":"KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34006303","citation_count":78,"is_preprint":false},{"pmid":"16520382","id":"PMC_16520382","title":"Sos-mediated activation of rac1 by p66shc.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16520382","citation_count":78,"is_preprint":false},{"pmid":"20460433","id":"PMC_20460433","title":"Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway.","date":"2010","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/20460433","citation_count":77,"is_preprint":false},{"pmid":"29141223","id":"PMC_29141223","title":"Gradients of Rac1 Nanoclusters Support Spatial Patterns of Rac1 Signaling.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29141223","citation_count":76,"is_preprint":false},{"pmid":"24244677","id":"PMC_24244677","title":"Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24244677","citation_count":73,"is_preprint":false},{"pmid":"29723737","id":"PMC_29723737","title":"Compartmentalisation of RAC1 signalling.","date":"2018","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29723737","citation_count":71,"is_preprint":false},{"pmid":"31484924","id":"PMC_31484924","title":"Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31484924","citation_count":70,"is_preprint":false},{"pmid":"30250061","id":"PMC_30250061","title":"Fam49/CYRI interacts with Rac1 and locally suppresses protrusions.","date":"2018","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30250061","citation_count":70,"is_preprint":false},{"pmid":"32122794","id":"PMC_32122794","title":"Sarcoidosis and the mTOR, Rac1, and Autophagy Triad.","date":"2020","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32122794","citation_count":69,"is_preprint":false},{"pmid":"11369774","id":"PMC_11369774","title":"Rac1 protects epithelial cells against anoikis.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11369774","citation_count":69,"is_preprint":false},{"pmid":"32178475","id":"PMC_32178475","title":"Rac1 Signaling: From Intestinal Homeostasis to Colorectal Cancer Metastasis.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32178475","citation_count":68,"is_preprint":false},{"pmid":"25818528","id":"PMC_25818528","title":"Modulation of actin dynamics by Rac1 to target cognitive function.","date":"2015","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25818528","citation_count":63,"is_preprint":false},{"pmid":"16195887","id":"PMC_16195887","title":"Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier.","date":"2005","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16195887","citation_count":63,"is_preprint":false},{"pmid":"22075250","id":"PMC_22075250","title":"Rap1-Rac1 circuits potentiate platelet activation.","date":"2011","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22075250","citation_count":63,"is_preprint":false},{"pmid":"26176707","id":"PMC_26176707","title":"RAC1 P29S regulates PD-L1 expression in melanoma.","date":"2015","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/26176707","citation_count":63,"is_preprint":false},{"pmid":"12393632","id":"PMC_12393632","title":"DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12393632","citation_count":63,"is_preprint":false},{"pmid":"30446664","id":"PMC_30446664","title":"Optogenetic dissection of Rac1 and Cdc42 gradient shaping.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30446664","citation_count":62,"is_preprint":false},{"pmid":"16357302","id":"PMC_16357302","title":"Selective Rac-1 inhibition protects from diabetes-induced vascular injury.","date":"2005","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16357302","citation_count":61,"is_preprint":false},{"pmid":"16802292","id":"PMC_16802292","title":"Alsin/Rac1 signaling controls survival and growth of spinal motoneurons.","date":"2006","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16802292","citation_count":59,"is_preprint":false},{"pmid":"27888097","id":"PMC_27888097","title":"Rab7a regulates cell migration through Rac1 and vimentin.","date":"2016","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27888097","citation_count":58,"is_preprint":false},{"pmid":"16467473","id":"PMC_16467473","title":"Rac1 and Cdc42 have different roles in Candida albicans development.","date":"2006","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/16467473","citation_count":57,"is_preprint":false},{"pmid":"23197717","id":"PMC_23197717","title":"Rac1 controls Schwann cell myelination through cAMP and NF2/merlin.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23197717","citation_count":56,"is_preprint":false},{"pmid":"17984089","id":"PMC_17984089","title":"The IQGAP1-Rac1 and IQGAP1-Cdc42 interactions: interfaces differ between the complexes.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17984089","citation_count":56,"is_preprint":false},{"pmid":"16228016","id":"PMC_16228016","title":"Yersinia pseudotuberculosis spatially controls activation and misregulation of host cell Rac1.","date":"2005","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/16228016","citation_count":56,"is_preprint":false},{"pmid":"18684957","id":"PMC_18684957","title":"Beta-PIX and Rac1 GTPase mediate trafficking and negative regulation of NOD2.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18684957","citation_count":55,"is_preprint":false},{"pmid":"32460002","id":"PMC_32460002","title":"RAC1 as a Therapeutic Target in Malignant Melanoma.","date":"2020","source":"Trends in cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32460002","citation_count":54,"is_preprint":false},{"pmid":"15102830","id":"PMC_15102830","title":"Diacylglycerol kinase gamma serves as an upstream suppressor of Rac1 and lamellipodium formation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15102830","citation_count":54,"is_preprint":false},{"pmid":"15093747","id":"PMC_15093747","title":"Regulation of anoikis by Cdc42 and Rac1.","date":"2004","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15093747","citation_count":54,"is_preprint":false},{"pmid":"27314616","id":"PMC_27314616","title":"GEFs: Dual regulation of Rac1 signaling.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/27314616","citation_count":53,"is_preprint":false},{"pmid":"30544910","id":"PMC_30544910","title":"Post-Translational Modification and Subcellular Distribution of Rac1: An Update.","date":"2018","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/30544910","citation_count":53,"is_preprint":false},{"pmid":"25043657","id":"PMC_25043657","title":"mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.","date":"2014","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/25043657","citation_count":50,"is_preprint":false},{"pmid":"25345393","id":"PMC_25345393","title":"Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases.","date":"2014","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/25345393","citation_count":49,"is_preprint":false},{"pmid":"17032649","id":"PMC_17032649","title":"Rac1 GTPase regulates cell genomic stability and senescence.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17032649","citation_count":48,"is_preprint":false},{"pmid":"31422887","id":"PMC_31422887","title":"Transient Activations of Rac1 at the Lamellipodium Tip Trigger Membrane Protrusion.","date":"2019","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/31422887","citation_count":48,"is_preprint":false},{"pmid":"27725632","id":"PMC_27725632","title":"Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27725632","citation_count":47,"is_preprint":false},{"pmid":"19126201","id":"PMC_19126201","title":"Rac1 regulates pancreatic islet morphogenesis.","date":"2009","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19126201","citation_count":45,"is_preprint":false},{"pmid":"29059171","id":"PMC_29059171","title":"Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29059171","citation_count":45,"is_preprint":false},{"pmid":"35853497","id":"PMC_35853497","title":"Rac1 as a therapeutic anticancer target: Promises and limitations.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35853497","citation_count":43,"is_preprint":false},{"pmid":"16723384","id":"PMC_16723384","title":"Regulation of cell-matrix adhesion dynamics and Rac-1 by integrin linked kinase.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/16723384","citation_count":43,"is_preprint":false},{"pmid":"26634649","id":"PMC_26634649","title":"Distinct predictive performance of Rac1 and Cdc42 in cell migration.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26634649","citation_count":40,"is_preprint":false},{"pmid":"17085464","id":"PMC_17085464","title":"NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model.","date":"2006","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/17085464","citation_count":38,"is_preprint":false},{"pmid":"25465943","id":"PMC_25465943","title":"RAC1 and melanoma.","date":"2014","source":"Clinical therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25465943","citation_count":37,"is_preprint":false},{"pmid":"25315346","id":"PMC_25315346","title":"Rac1 signaling is critical to cardiomyocyte polarity and embryonic heart development.","date":"2014","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/25315346","citation_count":37,"is_preprint":false},{"pmid":"27790713","id":"PMC_27790713","title":"Emerging roles of RAC1 in treating lung cancer patients.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27790713","citation_count":36,"is_preprint":false},{"pmid":"24297929","id":"PMC_24297929","title":"GluN3A expression restricts spine maturation via inhibition of GIT1/Rac1 signaling.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24297929","citation_count":36,"is_preprint":false},{"pmid":"35405309","id":"PMC_35405309","title":"Overexpressed or hyperactivated Rac1 as a target to treat hepatocellular carcinoma.","date":"2022","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/35405309","citation_count":35,"is_preprint":false},{"pmid":"24790223","id":"PMC_24790223","title":"CDC-42 and RAC-1 regulate opposite chemotropisms in Neurospora crassa.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24790223","citation_count":34,"is_preprint":false},{"pmid":"22946057","id":"PMC_22946057","title":"Upon Wnt stimulation, Rac1 activation requires Rac1 and Vav2 binding to p120-catenin.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22946057","citation_count":34,"is_preprint":false},{"pmid":"12117970","id":"PMC_12117970","title":"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.","date":"2002","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12117970","citation_count":34,"is_preprint":false},{"pmid":"25289457","id":"PMC_25289457","title":"Redox regulation of Rac1 by thiol oxidation.","date":"2014","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25289457","citation_count":33,"is_preprint":false},{"pmid":"23298303","id":"PMC_23298303","title":"Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma.","date":"2013","source":"Asia-Pacific journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23298303","citation_count":32,"is_preprint":false},{"pmid":"15170282","id":"PMC_15170282","title":"Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma.","date":"2004","source":"Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/15170282","citation_count":32,"is_preprint":false},{"pmid":"22349701","id":"PMC_22349701","title":"Association of syntenin-1 with M-RIP polarizes Rac-1 activation during chemotaxis and immune interactions.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22349701","citation_count":32,"is_preprint":false},{"pmid":"19852956","id":"PMC_19852956","title":"Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration.","date":"2009","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19852956","citation_count":30,"is_preprint":false},{"pmid":"32019972","id":"PMC_32019972","title":"Rac1 is a downstream effector of PKCα in structural synaptic plasticity.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32019972","citation_count":29,"is_preprint":false},{"pmid":"16002401","id":"PMC_16002401","title":"Regulation of p21-activated kinase-independent Rac1 signal transduction by nischarin.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16002401","citation_count":28,"is_preprint":false},{"pmid":"32783108","id":"PMC_32783108","title":"IQGAP1 causes choroidal neovascularization by sustaining VEGFR2-mediated Rac1 activation.","date":"2020","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/32783108","citation_count":27,"is_preprint":false},{"pmid":"38387701","id":"PMC_38387701","title":"Implication of Rac1 GTPase in molecular and cellular mitochondrial functions.","date":"2024","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38387701","citation_count":26,"is_preprint":false},{"pmid":"19940064","id":"PMC_19940064","title":"CCK activates RhoA and Rac1 differentially through Galpha13 and Galphaq in mouse pancreatic acini.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19940064","citation_count":26,"is_preprint":false},{"pmid":"21883766","id":"PMC_21883766","title":"Rac1 and calmodulin interactions modulate dynamics of ARF6-dependent endocytosis.","date":"2011","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/21883766","citation_count":26,"is_preprint":false},{"pmid":"32533921","id":"PMC_32533921","title":"Prenylation of Axonally Translated Rac1 Controls NGF-Dependent Axon Growth.","date":"2020","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/32533921","citation_count":25,"is_preprint":false},{"pmid":"26305333","id":"PMC_26305333","title":"Rac1 Regulates Endometrial Secretory Function to Control Placental Development.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26305333","citation_count":25,"is_preprint":false},{"pmid":"33299404","id":"PMC_33299404","title":"Stress-Sensitive Protein Rac1 and Its Involvement in Neurodevelopmental Disorders.","date":"2020","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/33299404","citation_count":24,"is_preprint":false},{"pmid":"33848152","id":"PMC_33848152","title":"Mechanistic Differences of Activation of Rac1P29S and Rac1A159V.","date":"2021","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/33848152","citation_count":24,"is_preprint":false},{"pmid":"19487462","id":"PMC_19487462","title":"Rac1 signaling modulates BCL-6-mediated repression of gene transcription.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19487462","citation_count":24,"is_preprint":false},{"pmid":"35154488","id":"PMC_35154488","title":"Hedgehog signaling is controlled by Rac1 activity.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/35154488","citation_count":23,"is_preprint":false},{"pmid":"29886834","id":"PMC_29886834","title":"Verbascoside Attenuates Rac-1 and HIF-1α Signaling Cascade in Colorectal Cancer Cells.","date":"2018","source":"Anti-cancer agents in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29886834","citation_count":23,"is_preprint":false},{"pmid":"28410221","id":"PMC_28410221","title":"Discovery and characterization of small molecule Rac1 inhibitors.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28410221","citation_count":23,"is_preprint":false},{"pmid":"32460619","id":"PMC_32460619","title":"TNFAIP8L2/TIPE2 impairs autolysosome reformation via modulating the RAC1-MTORC1 axis.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/32460619","citation_count":22,"is_preprint":false},{"pmid":"30594931","id":"PMC_30594931","title":"Rac1 Activity Is Modulated by Huntingtin and Dysregulated in Models of Huntington's Disease.","date":"2019","source":"Journal of Huntington's disease","url":"https://pubmed.ncbi.nlm.nih.gov/30594931","citation_count":22,"is_preprint":false},{"pmid":"28622072","id":"PMC_28622072","title":"New model for the interaction of IQGAP1 with CDC42 and RAC1.","date":"2017","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/28622072","citation_count":21,"is_preprint":false},{"pmid":"37735908","id":"PMC_37735908","title":"Force-Loaded Cementocytes Regulate Osteoclastogenesis via S1P/S1PR1/Rac1 Axis.","date":"2023","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/37735908","citation_count":21,"is_preprint":false},{"pmid":"32224866","id":"PMC_32224866","title":"mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated Glioma.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32224866","citation_count":21,"is_preprint":false},{"pmid":"33849538","id":"PMC_33849538","title":"Rac1 activation can generate untemplated, lamellar membrane ruffles.","date":"2021","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/33849538","citation_count":21,"is_preprint":false},{"pmid":"32746999","id":"PMC_32746999","title":"Rho A and Rac1: Antagonists moving forward.","date":"2020","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/32746999","citation_count":20,"is_preprint":false},{"pmid":"26036474","id":"PMC_26036474","title":"The Ins and Outs of Small GTPase Rac1 in the Vasculature.","date":"2015","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26036474","citation_count":20,"is_preprint":false},{"pmid":"24819662","id":"PMC_24819662","title":"Elmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancer.","date":"2014","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/24819662","citation_count":20,"is_preprint":false},{"pmid":"7534315","id":"PMC_7534315","title":"Expression of alpha 1-chimaerin (rac-1 GAP) alters the cytoskeletal and adhesive properties of fibroblasts.","date":"1994","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7534315","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49036,"output_tokens":13215,"usd":0.172667,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":24708,"output_tokens":11174,"usd":0.201445,"stage2_stop_reason":"end_turn"},"total_usd":0.374112,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Activated Rac1 (and Cdc42) interacts with IQGAP1, and IQGAP1 in turn binds CLIP-170, forming a tripartite Rac1/Cdc42–IQGAP1–CLIP-170 complex that captures microtubule plus-ends at the cortical leading edge to polarize the microtubule array and establish cell polarity. Expression of an IQGAP1 mutant defective in Rac1/Cdc42 binding induces multiple leading edges.\",\n      \"method\": \"Co-immunoprecipitation, GFP-fusion live imaging, dominant-negative/truncation expression in Vero fibroblasts\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, functional rescue/dominant-negative, live imaging; findings replicated across multiple constructs in a single rigorous study\",\n      \"pmids\": [\"12110184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The Salmonella Typhimurium effector SptP acts as a GAP (GTPase-activating protein) directly for Rac-1 and Cdc42, stimulating GTP hydrolysis and thereby reversing the actin cytoskeletal changes (membrane ruffling) induced by bacterial invasion.\",\n      \"method\": \"In vitro GAP assay with purified SptP and Rac-1/Cdc42, cell-based phenotypic rescue\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro biochemical assay with purified proteins demonstrating GAP activity; published in high-tier journal with clear mechanistic read-out\",\n      \"pmids\": [\"10499590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Both Rac1 and Cdc42 are required for FcγR-mediated phagocytosis and for membrane ruffling in macrophages; dominant-inhibitory Rac1 N17 blocks phagocytic cup formation and particle internalization without fully blocking F-actin accumulation, indicating a role downstream of actin recruitment in membrane remodeling.\",\n      \"method\": \"Expression of dominant-negative Rac1 N17 and Cdc42 N17 in transfected RAW 264.7 macrophages; F-actin staining; phagocytosis assay\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean dominant-negative loss-of-function with defined phagocytic phenotype, replicated across multiple receptor stimuli\",\n      \"pmids\": [\"9348306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Dominant-inhibitory Rac1 blocks particle internalization and prevents phagocytic cup closure during FcεRI-mediated phagocytosis in RBL-2H3 mast cells; Rac1 and CDC42 have distinct functions (Rac1-inhibited cells show thin membrane protrusions that fail to fuse, while CDC42-inhibited cells show pedestal-like structures), and inhibition of both is accompanied by persistence of phosphotyrosine around bound particles, suggesting Rac1 coordinates actin organization and membrane extension.\",\n      \"method\": \"Stable transfection of dominant-negative Rac1 and CDC42 in RBL-2H3 cells; F-actin staining; phagocytosis assay; phosphotyrosine immunofluorescence\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — stable dominant-negative cell lines with orthogonal phenotypic readouts (phagocytosis, morphology, phosphotyrosine); independent replication of the Rac1 phagocytosis requirement\",\n      \"pmids\": [\"9799231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Rac1 is a required downstream component of the Vav oncogene signaling pathway that activates JNK/SAPK; co-expression of dominant-inhibitory Rac1 N17 dramatically reduces JNK/SAPK stimulation by oncogenic Vav and reduces Vav-induced focus formation in NIH3T3 cells, establishing Rac1 as an effector linking Vav (a Rho-family GEF) to the JNK/SAPK kinase cascade.\",\n      \"method\": \"Transient co-expression in COS-7 cells; JNK/SAPK kinase assay; focus-formation assay in NIH3T3 cells with dominant-negative Rac1\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via dominant-negative plus kinase activity assay; single lab but two independent functional readouts\",\n      \"pmids\": [\"8760286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rac1 C-terminus (polybasic region) is necessary and sufficient to constitutively associate with a type I PtdInsP 5-kinase and a diacylglycerol kinase (DGK) independent of GTP-loading; RhoGDI associates with this lipid kinase complex primarily via its interaction with Rac1; specific phospholipids enhance the Rac–lipid kinase interaction.\",\n      \"method\": \"In vitro binding with chimeric/truncation/peptide Rac1 constructs; co-purification by liquid chromatography; in vivo co-immunoprecipitation with RhoGDI\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with domain mapping (chimeras, peptides, truncations) plus reciprocal co-IP; single lab with multiple orthogonal biochemical methods\",\n      \"pmids\": [\"9447972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Rac1, in its GTP-bound form, directly binds alpha- and beta-tubulin via its effector domain (D38A mutation abolishes interaction); GTPase-dead mutants G12V and Q61L retain tubulin binding, indicating the interaction requires the active conformation but not GTP hydrolysis.\",\n      \"method\": \"Overlay binding assay with [γ-32P]GTP-labeled Rac1 on cell extract nitrocellulose; purification and identification of 55-kDa binding proteins as tubulin; binding assay with purified tubulin and Rac1 point mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified tubulin, systematic effector-domain mutagenesis; single lab but rigorous biochemical controls\",\n      \"pmids\": [\"8631991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Membrane recruitment of activated Rac1 alone is sufficient to trigger actin polymerization and phagocytic particle internalization; the Rac1 effector-loop mutation F37L abolishes this activity, demonstrating that phagocytosis requires downstream effector binding by Rac1.\",\n      \"method\": \"Rapamycin-inducible membrane-recruitment system (FKBP–FRB bridge) for activated Rac1; actin immunofluorescence; latex bead internalization assay; cytochalasin D inhibition; site-directed mutagenesis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution via inducible membrane-targeting with effector-loop mutagenesis; clean mechanistic design in a single rigorous study\",\n      \"pmids\": [\"10934035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Genetic deletion of both Rac1 and Rac2 in mice causes massive egress of hematopoietic stem/progenitor cells from bone marrow; Rac1 specifically (not Rac2) is required for HSC/P engraftment in irradiated recipients; Rac2 (not Rac1) regulates superoxide production and directed neutrophil migration, demonstrating non-redundant isoform-specific roles.\",\n      \"method\": \"Conditional gene targeting (Rac1−/−, Rac2−/−, Rac1/2 double KO) in mice; bone marrow transplantation; NADPH oxidase/superoxide assay; migration assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with multiple defined in vivo and in vitro phenotypic readouts; isoform specificity established by parallel KO comparison\",\n      \"pmids\": [\"14564009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Conditional deletion of Rac1 in adult mouse epidermis drives epidermal stem cells to divide and undergo terminal differentiation; Rac1 exerts this effect by negatively regulating c-Myc through PAK2 phosphorylation, placing Rac1 upstream of PAK2 and c-Myc in the stem cell regulatory axis.\",\n      \"method\": \"Inducible conditional Rac1 KO in mouse epidermis; histology; BrdU incorporation; immunostaining for c-Myc and PAK2; epistasis analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with defined stem cell phenotype plus pathway placement via PAK2–c-Myc epistasis in a single rigorous in vivo study\",\n      \"pmids\": [\"16081735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Rac1 is required in cardiomyocytes for NADPH oxidase activation and cardiac hypertrophy: cardiac-specific Rac1 deletion abolishes gp91(phox)–p67(phox) interaction, reduces NADPH oxidase activity and myocardial oxidative stress, and attenuates angiotensin II–induced hypertrophy in vivo.\",\n      \"method\": \"Cardiomyocyte-specific inducible Rac1 KO mice; co-immunoprecipitation of gp91(phox) and p67(phox); NADPH oxidase activity assay; ROS measurement; echocardiography\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple orthogonal biochemical readouts (co-IP, enzyme activity, ROS) plus in vivo hypertrophic phenotype\",\n      \"pmids\": [\"16651530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rac1 signaling promotes chondrogenesis and N-cadherin expression in mesenchymal precursors; pharmacological or genetic inhibition of Rac1 reduces Sox9/Sox5/Sox6 transcription factor expression and cartilage markers, while Rac1 overexpression increases them; Rac1 and Cdc42 act through partially distinct mechanisms during chondrogenesis.\",\n      \"method\": \"Pharmacological Rac1 inhibition and dominant-active overexpression in micromass cultures and ATDC5 cells; conditional Rac1 KO primary micromass cultures; RT-PCR; immunoblot; N-cadherin staining\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus gain-of-function with multiple molecular readouts; single lab\",\n      \"pmids\": [\"17573353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Rac1 and Cdc42 promote chondrocyte hypertrophy and apoptosis through activation of the p38 MAP kinase pathway; pharmacological p38 inhibition blocks the effects of Rac1 and Cdc42 overexpression on hypertrophy and apoptosis, and Rac1/Cdc42 activity is required for maximal collagen X promoter activity, antagonizing RhoA signaling.\",\n      \"method\": \"Transient/stable transfection in primary chondrocytes and ATDC5 cells; luciferase reporter; TUNEL assay; caspase activity; phospho-p38 immunoblot; p38 inhibitor epistasis\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via pharmacological inhibitor plus gain-of-function with multiple orthogonal readouts; single lab\",\n      \"pmids\": [\"15883643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The centralspindlin component CYK4 functions as a GAP specifically for Rac1 (not RhoA) at the cell equator during anaphase; CYK4 GAP activity suppresses Rac1-dependent ARHGEF7 and PAK1 effector pathways required for cell adhesion, thereby spatially segregating cell adhesion from contractile ring activity during cytokinesis.\",\n      \"method\": \"In vitro GAP assay with purified CYK4; CYK4 GAP mutant expression; depletion of ARHGEF7/PAK1 rescue experiments; vinculin staining; cytokinesis phenotyping\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro GAP activity assay plus genetic epistasis rescue; mechanism supported by both biochemistry and cell biology\",\n      \"pmids\": [\"22945935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"p66shc increases the Rac1-specific GEF activity of Sos1 by displacing Sos1 from Grb2 (via competition of the PPLP motif in the p66shc CH2 domain for the C-SH3 domain of Grb2) and promoting formation of the Sos1–Eps8–E3b1 tricomplex, resulting in Rac1 activation and oxidative stress.\",\n      \"method\": \"In vitro GEF activity assay; co-immunoprecipitation of Sos1/Grb2/Eps8/E3b1; domain-mapping with CH2 mutants; Rac1 activation assay (GST-PBD pulldown)\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro GEF assay plus reciprocal co-IP and domain mutagenesis; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16520382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Rac1 binds the adaptor protein caveolin-1 (Cav1); Rac1 activity promotes Cav1 accumulation at peripheral adhesions; Cav1 controls Rac1 protein levels by regulating ubiquitylation and proteasomal degradation of activated (GTP-bound) Rac1 in an adhesion-dependent manner, providing a non-canonical mechanism to terminate Rac1 signaling.\",\n      \"method\": \"Co-immunoprecipitation; Cav1-KO fibroblasts; siRNA/shRNA depletion; ubiquitylation assay; effector-binding assay with ubiquitylation-deficient Rac1 mutant\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, KO cells, ubiquitylation assay, and effector-binding controls in a single study; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"20460433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Rac1 partitions into nanoclusters of 50–100 molecules at the plasma membrane through interaction of its polybasic tail with PIP2 and PIP3; additional interactions with GEFs, GAPs, and effectors enrich nanoclusters in protruding regions, generating spatial gradients of Rac1 signaling nanodomains.\",\n      \"method\": \"Single-molecule imaging (SPT); super-resolution microscopy (PALM/STORM); pharmacological lipid perturbation\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — super-resolution and single-molecule imaging with lipid-interaction mechanistic testing; single lab\",\n      \"pmids\": [\"29141223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cdc42 and Rac1 gradients during cell migration are set by spatial patterns of GEFs and GAPs, not by transport; Rac1 gradient shaping specifically requires the GAP β2-chimaerin, which is localized to the cell tip through feedbacks from both Cdc42 and Rac1; the spatial extent of the Rac1 gradient controls cell migration speed.\",\n      \"method\": \"Optogenetics (light-controlled GEF recruitment); micropatterning; FRET biosensor imaging; β2-chimaerin KO/depletion\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — optogenetic perturbation combined with biosensor imaging and genetic KO; multiple orthogonal approaches in a single study\",\n      \"pmids\": [\"30446664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rac1 and Cdc42 use partially overlapping but distinct binding interfaces on IQGAP1: switch II residues Asp-63, Arg-68, and Leu-70 are critical for Rac1–IQGAP1 binding but not for Cdc42–IQGAP1 binding; residues 32 and 36 in switch I affect both; the Rho insert loop does not contribute; IQGAP1 and RhoGAP binding sites on Rac1 overlap only partially.\",\n      \"method\": \"Site-directed mutagenesis of Rac1 and Cdc42; binding affinity measurements (ITC/fluorescence); competition assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with quantitative binding measurements; multiple mutants tested in parallel for two GTPases\",\n      \"pmids\": [\"17984089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Yersinia pseudotuberculosis YopE RhoGAP inactivates the membrane-associated pool of Rac1 globally, while YopT protease removes Rac1's membrane-targeting motif, releasing activated Rac1 into the cytoplasm/nucleus where it interacts with nuclear GEFs; the two effectors compete for membrane-associated Rac1, producing two spatially distinct pools with different activation states.\",\n      \"method\": \"FRET-based Rac1 activation biosensor imaging in living cells; bacterial infection with YopE and YopT mutant strains\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live FRET imaging with genetic bacterial mutant strains; single lab\",\n      \"pmids\": [\"16228016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DGKγ (diacylglycerol kinase gamma) acts as an upstream suppressor of Rac1 via its catalytic activity; kinase-dead DGKγ (dominant-negative) selectively activates Rac1 (not Cdc42) and induces lamellipodia, while constitutively active DGKγ suppresses PDGF-induced lamellipodia; endogenous DGKγ co-immunoprecipitates with Rac1; dominant-negative Rac1 blocks lamellipodia induced by kinase-dead DGKγ, placing DGKγ upstream of Rac1.\",\n      \"method\": \"Expression of kinase-dead and constitutively active DGKγ mutants; co-immunoprecipitation; dominant-negative Rac1 epistasis; Rac1 activation assay (GST-PBD pulldown); confocal co-localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis with dominant-negative plus co-IP and activation assay; single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"15102830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"S6K1 acts upstream of Rac1 during platelet activation on fibrinogen; S6K1 and Rac1 interact in a protein complex with the Rac1 GEF TIAM1 and co-localize with actin at the platelet lamellipodial edge; mTOR inhibitors block Rac1 activation and platelet spreading without affecting Src or FAK, placing mTOR–S6K1 upstream of Rac1 in this pathway.\",\n      \"method\": \"Co-immunoprecipitation (S6K1–Rac1–TIAM1 complex); pharmacological inhibition of S6K1, mTOR, Src, FAK; Rac1 activation assay; platelet spreading assay under shear flow\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of tricomplex plus pharmacological epistasis; single lab\",\n      \"pmids\": [\"21757621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DOCK2 associates with CrkL (via two separate DOCK2 regions binding the CrkL SH3 domain) in hematopoietic cells; a DOCK2-dCS mutant that cannot bind CrkL significantly inhibits CrkL-induced Rac1 activation; DOCK2 also associates with the Rac1 GEF Vav in Jurkat cells, placing DOCK2 in a CrkL–DOCK2–Vav complex upstream of Rac1.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro); GST pulldown; Rac1 activation assay; immunocytochemistry\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with domain mapping and Rac1 activation assay; single lab\",\n      \"pmids\": [\"12393632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rac1 forms a nuclear complex with the GEF Tiam1 and the transcription factor RORγt in Th17 cells; this complex binds and activates the Il17a promoter; deletion of Rac1 in T cells more potently reduces IL-17A expression and EAE than Tiam1 deficiency alone.\",\n      \"method\": \"Co-immunoprecipitation of Tiam1/Rac1/RORγt complex; ChIP at the Il17 promoter; T-cell-specific Rac1 KO mice; EAE model; pharmacological Rac1 inhibition\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — nuclear complex demonstrated by co-IP plus ChIP; genetic KO plus pharmacological inhibition with defined transcriptional and in vivo phenotype\",\n      \"pmids\": [\"27725632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Schwann cell myelination requires Rac1; Rac1 KO abrogates PAK phosphorylation and reduces NF2/merlin phosphorylation; NF2/merlin mutation rescues myelin deficits in Rac1-CKO mice; cAMP levels are reduced in Rac1-CKO SCs and elevation of cAMP restores myelination, placing NF2/merlin and cAMP downstream of Rac1 in a myelination pathway.\",\n      \"method\": \"Conditional Rac1 KO in Schwann cells; immunoblot for phospho-PAK and phospho-merlin; genetic rescue with NF2/merlin mutant in vivo; rolipram (cAMP elevation) pharmacological rescue in vivo\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with in vivo genetic and pharmacological rescue; multiple orthogonal pathway readouts\",\n      \"pmids\": [\"23197717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Constitutively active Rac1-V12 inhibits anoikis (suspension-induced apoptosis) in MDCK epithelial cells by reducing caspase activity and DNA fragmentation; Rac1-mediated survival depends on PI3K activity; ERK, p38, and NF-κB pathways are activated by Rac1-V12 but are largely dispensable for the survival effect.\",\n      \"method\": \"Expression of Rac1-V12 in MDCK cells in suspension; caspase assay; DNA fragmentation; pharmacological inhibition of PI3K, ERK, p38, NF-κB\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function plus pharmacological pathway dissection with multiple readouts; single lab\",\n      \"pmids\": [\"11369774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCK activates Rac1 in pancreatic acini through Gα13 and Gαq acting cooperatively (but not Gαs or Gαi); RGS-2 (Gαq inhibitor) and p115-RGS (Gα12/13 inhibitor) both abolish CCK-induced Rac1 activation via a PLC-independent pathway; RhoA is activated exclusively through Gα13.\",\n      \"method\": \"Active Gα expression constructs; Rac1/RhoA activation assays (pulldown); RGS domain inhibitors; RT-PCR and western for Gα13\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct GTPase activation assays with specific Gα inhibitory domains; single lab\",\n      \"pmids\": [\"19940064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NOD2 stimulation activates Rac1 in human monocytes; β-PIX co-immunoprecipitates with NOD2 and Rac1 upon MDP stimulation; knockdown of β-PIX or Rac1 abrogates membrane recruitment of NOD2 and NOD2 interaction with its negative regulator Erbin, demonstrating that β-PIX–Rac1 mediate NOD2 trafficking and negative feedback regulation.\",\n      \"method\": \"Rac1 activation assay; co-immunoprecipitation of NOD2–β-PIX–Rac1; siRNA knockdown; immunofluorescence for NOD2 membrane localization; IL-8/NF-κB reporter\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus siRNA with membrane localization and functional output; single lab\",\n      \"pmids\": [\"18684957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Integrin-linked kinase (ILK) activates Rac1 via β-PIX; ILK associates with PKL and the Rac1/Cdc42 GEF β-PIX; dominant-negative β-PIX reverses ILK-induced Rac1 activation; ILK knockdown reduces active Rac1 levels, placing β-PIX downstream of ILK and upstream of Rac1 in integrin-mediated cell spreading.\",\n      \"method\": \"Co-immunoprecipitation of ILK–PKL–β-PIX; Rac1 activation assay (GST-PBD pulldown); siRNA knockdown; dominant-negative β-PIX epistasis; ILK-GFP-F overexpression\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of complex plus epistasis with dominant-negative and siRNA; single lab\",\n      \"pmids\": [\"16723384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GluN3A-containing NMDA receptors bind GIT1, limiting GIT1 synaptic localization and its ability to complex β-PIX, thereby decreasing Rac1 activation and PAK phosphorylation in spines and reducing spine density/size; knockdown of GluN3A increases GIT1/β-PIX complex formation and Rac1/PAK activation. GluN3A–GIT1 binding is regulated by synaptic activity.\",\n      \"method\": \"Co-immunoprecipitation of GluN3A–GIT1; Rac1 activation assay; GluN3A KO mice; shRNA knockdown; immunofluorescence; PAK phosphorylation immunoblot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, KO mice, shRNA loss-of-function with multiple orthogonal biochemical and morphological readouts\",\n      \"pmids\": [\"24297929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Rac1 contains a redox-sensitive cysteine (Cys18) with a lowered pKa; oxidation of Cys18 by glutathione (glutathiolation) greatly perturbs guanine nucleotide binding and promotes nucleotide exchange, activating Rac1; Rac1 is glutathiolated in primary chondrocytes; the C18D mimetic mutant shows enhanced GTP-loading and promotes lamellipodia formation in cells.\",\n      \"method\": \"Mass spectrometry identification of glutathiolation; in vitro nucleotide-exchange assay with oxidized Rac1; pKa measurement; C18D/C18S mutagenesis; GTP-bound Rac1 pulldown in cells; lamellipodia formation assay\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution with mutagenesis plus cell-based validation; multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"25289457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Alsin, a GEF for Rac1 (and Rab5), supports motoneuron survival and axon growth through Rac1 signaling; alsin knockdown–induced cell death and reduced axon growth are mimicked by dominant-negative Rac1 and fully rescued by constitutively active Rac1, while dominant-negative/active Rab5 has no such effect.\",\n      \"method\": \"siRNA knockdown of alsin in embryonic rat spinal motoneurons; expression of dominant-negative and constitutively active Rac1 and Rab5; cell survival counting; axon length measurement\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via gain- and loss-of-function with isoform-specific controls; single lab\",\n      \"pmids\": [\"16802292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Loss or gain of Rac1 activity induces premature senescence in primary MEFs through increased reactive oxygen species (ROS) production and p53 activation (phospho-Ser15); ROS inhibitor blocks DNA damage foci formation; genetic p53 deletion reverses senescence in both Rac1−/− and L61Rac1 cells, placing ROS-mediated genomic instability and p53 upstream of Rac1-regulated senescence.\",\n      \"method\": \"Rac1 gene-targeted MEFs; constitutively active L61Rac1; ROS measurement; TUNEL; phospho-H2AX foci; p53 phosphorylation; p53 genetic deletion epistasis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus gain-of-function with p53 epistasis; single lab with multiple readouts\",\n      \"pmids\": [\"17032649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Non-prenylated Rac1 has high affinity for IQGAP1, which facilitates both GTP exchange and ubiquitination-mediated degradation of Rac1; inactivating IQGAP1 normalizes Rac1 GTP-loading and reduces inflammation; heterozygous Rac1 deletion (but not Rhoa or Cdc42) reverses arthritis in GGTase-I-deficient mice. Prenylation of Rac1 by GGTase-I therefore normally restrains Rac1 effector interactions.\",\n      \"method\": \"Rac1+/− genetic rescue in GGTase-I KO mice; IQGAP1 KO mice; co-immunoprecipitation and ubiquitination assays; Rac1 GTP-loading assay; inflammatory phenotype scoring\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic rescue experiments with two independent KOs plus biochemical mechanism; multiple orthogonal approaches\",\n      \"pmids\": [\"31484924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CYRI (Fam49) binds activated Rac1 via its DUF1394 domain, locally suppresses Scar/WAVE recruitment at the cell edge, limits protrusion size and duration, and thereby regulates pseudopod polarity, chemotaxis, and epithelial polarization; CYRI-depleted cells show larger, longer-lived optogenetically induced pseudopods.\",\n      \"method\": \"Co-immunoprecipitation and biochemical binding assay (DUF1394–Rac1); CYRI KO/overexpression; optogenetic Rac1 activation; Scar/WAVE immunofluorescence; migration/chemotaxis assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding demonstrated biochemically plus KO/OE with optogenetic and functional assays; multiple orthogonal methods\",\n      \"pmids\": [\"30054448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Transient immobilizations of activated Rac1 at the lamellipodium tip correlate with its activation and depend on effector binding including the WAVE regulatory complex (WRC); optogenetic Rac1 activation close to the lamellipodium tip (but not behind it) is required for efficient membrane protrusion; these data establish that short-lived Rac1 activation triggers WRC-dependent actin branching at the lamellipodium tip.\",\n      \"method\": \"Single-particle tracking (SPT); optogenetic Rac1 activation (Tiam1 membrane recruitment); Rac1 effector-loop mutants; WRC mutant cells; super-resolution imaging\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — optogenetics combined with SPT and effector-loop mutagenesis in a single mechanistic study\",\n      \"pmids\": [\"31422887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Activated Rac1 (Rac(V12)) induces upregulation of IL-6 family cytokines, which activate gp130/Stat3 signaling; gp130 knockdown reduces Stat3 activity, cell migration, and proliferation induced by Rac(V12), identifying gp130/Stat3 as an essential effector pathway downstream of activated Rac1.\",\n      \"method\": \"Expression of Rac1(V12) in HC11 cells; gp130 siRNA knockdown; Stat3 luciferase reporter; IL-6 mRNA quantification; cell migration/proliferation assays\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function plus siRNA epistasis with multiple readouts; single lab\",\n      \"pmids\": [\"19852956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Rac1 signaling inhibits the transcriptional repressor BCL-6; active Rac1 mutants cause BCL-6 to lose nuclear dot localization and become non-chromatin-bound, inducing expression of BCL-6 target genes NF-κB1/p105 and CD44; PAK1 mediates this inhibition downstream of Rac1 and can directly phosphorylate BCL-6; notably, the splice variant Rac1b does not stimulate these effects.\",\n      \"method\": \"Active Rac1 mutant transfection; NSC23766 pharmacological inhibition; luciferase reporter; fractionation/immunofluorescence for BCL-6; in vitro PAK1 kinase assay with BCL-6 substrate\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay for PAK1→BCL-6 plus cell-based gain/loss-of-function with fractionation; single lab\",\n      \"pmids\": [\"19487462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rac1 is sequentially activated downstream of Rap1/CalDAG-GEFI via GPVI in platelets; Rac1 in turn provides positive feedback for both CalDAG-GEFI- and P2Y12-dependent Rap1 activation via calcium mobilization and granule/ADP release; Rac1 controls lamellipodia formation, clot retraction, and granule release; two pools of Rac1 exist, one directly downstream of GPVI and one downstream of Rap1.\",\n      \"method\": \"Rac1 inhibitor EHT 1864 in platelets; CalDAG-GEFI/P2Y12 double KO mice; Rac1 activation assay; platelet spreading; calcium flux; clot retraction assay\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological plus genetic KO approaches with multiple platelet function readouts; single lab\",\n      \"pmids\": [\"22075250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Wnt3a stimulation activates Rac1 by promoting CK1-dependent phosphorylation of p120-catenin, enabling its release from E-cadherin and binding to the Rac1 GEF Vav2 and Rac1 itself; this trimeric p120-catenin/Vav2/Rac1 complex facilitates Rac1 activation; p120-catenin mutants defective in E-cadherin release or Vav2/Rac1 binding cannot rescue p120-catenin depletion in Xenopus gastrulation.\",\n      \"method\": \"Co-immunoprecipitation of p120-catenin/Vav2/Rac1; Rac1 activation assay; Src/Fyn and CK1 phosphorylation; Xenopus depletion/rescue assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with phosphorylation dissection plus in vivo Xenopus rescue; single lab\",\n      \"pmids\": [\"22946057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PKCα positively regulates Rac1 activation during single-spine structural plasticity in neurons; removal of PKCα from the postsynapse attenuates Rac1 (but not Ras or Cdc42) activation; disruption of PKCα's PDZ binding domain impairs both Rac1 activation and structural spine remodeling.\",\n      \"method\": \"Two-photon uncaging; FRET biosensors for Rac1, Cdc42, Ras in single spines; PKCα shRNA knockdown; PDZ-domain PKCα mutant\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-spine biosensor imaging with loss-of-function and domain mutant; single lab\",\n      \"pmids\": [\"32019972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NGF triggers prenylation (geranylgeranylation) of newly synthesized Rac1 in sympathetic axons in a local protein-synthesis-dependent manner; newly prenylated Rac1 localizes to TrkA-harboring endosomes in axons and promotes receptor trafficking necessary for axon growth; conditional KO of prenylation machinery abolishes sympathetic axon target innervation.\",\n      \"method\": \"Conditional KO of geranylgeranyltransferase in sympathetic neurons; axonal compartment isolation; prenylation assay in isolated axons; TrkA endosome co-localization; axon growth assays\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO plus compartmentalized biochemistry and imaging with multiple mechanistic readouts; single rigorous study\",\n      \"pmids\": [\"32533921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Expression of α1-chimaerin (a Rac1-specific GAP) in NIH3T3 fibroblasts reduces Rac1 activity (confirmed by in-extract GAP assay) and impairs actin stress fiber formation, focal adhesion assembly (vinculin clusters), and integrin-mediated adhesion to fibronectin following growth factor stimulation, establishing that GAP-mediated inactivation of Rac1 negatively regulates actin cytoskeletal organization.\",\n      \"method\": \"Stable transfection of α1-chimaerin; in-extract Rac1 GAP activity assay (regulated by phosphatidylserine/phorbol ester); actin/vinculin immunofluorescence; fibronectin adhesion assay\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in-extract GAP activity assay plus cell-based loss-of-function phenotype; single lab\",\n      \"pmids\": [\"7534315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rac1 and calmodulin (CaM) interact with high binding affinity through the Rac1 polybasic region and its prenyl group; CaM inhibition inactivates Rac1, increases Rac1–PIP5K interaction, and induces extensive PI4,5P2-positive tubular plasma-membrane invaginations via an ARF6-dependent clathrin-independent endocytic pathway; inactive Rac1 mutant expression enhances tubulation by recruiting PIP5K, while active Rac1 impairs it.\",\n      \"method\": \"Binding affinity measurements (Rac1–CaM); CaM inhibitor treatment; constitutively active/inactive Rac1 mutant expression; PI4,5P2 immunofluorescence; endocytosis assays\",\n      \"journal\": \"Traffic\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay plus gain/loss-of-function with endocytic phenotype; single lab\",\n      \"pmids\": [\"21883766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"IQGAP1 mediates sustained VEGF-induced Rac1 activation in choroidal endothelial cells via VEGFR2–Src–Rac1 signaling; IQGAP1 binding to Rac1-GTP sustains Rac1 activation; an IQGAP1 construct unable to bind Rac1 abolishes sustained Rac1 activation; Iqgap1−/− mice have reduced Rac1-GTP and choroidal neovascularization.\",\n      \"method\": \"IQGAP1 KO mice; IQGAP1-Rac1 binding-deficient mutant; Rac1-GTP pulldown; Src/VEGFR2 inhibition; CEC migration and tube formation assays; laser-induced CNV model\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mice plus domain-mutant rescue with multiple biochemical and in vivo readouts; multiple orthogonal methods\",\n      \"pmids\": [\"32783108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Smo activation by Hh ligand leads to Smo binding Vav2, increased Vav2 phosphorylation at Y172, and consequent Rac1 activation; active Rac1 then phosphorylates KIF3A at S689/T694, stabilizes IFT88, and dampens SuFu–Gli complex formation, enabling Gli nuclear translocation and Hh target gene expression; Rac1 deficiency in mouse limb bud ectoderm impedes Gli nuclear translocation.\",\n      \"method\": \"Co-immunoprecipitation of Smo–Vav2; Vav2 phosphorylation assay; Rac1 activation assay; KIF3A phosphorylation; IFT88 stability; SuFu–Gli co-IP; Rac1 conditional KO mouse; human MB tissue analysis\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple co-IPs and KO mouse with defined transcriptional readout; single lab with multiple molecular steps characterized\",\n      \"pmids\": [\"35154488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Thrombospondin–α2δ-1 interaction promotes synaptogenesis postsynaptically via Rac1; postsynaptic (but not presynaptic) α2δ-1 is required and sufficient for TSP-induced synaptogenesis and spine formation in vivo; an autism-linked α2δ-1 mutant cannot rescue these defects.\",\n      \"method\": \"Cell-type-specific KO of α2δ-1; TSP-induced synaptogenesis assay; Rac1 activation assay; electron microscopy; in vivo spine counting\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-specific KO with Rac1 activation assay and multiple synapse readouts; single lab\",\n      \"pmids\": [\"30054448\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAC1 is a Rho-family small GTPase that cycles between GDP-bound (inactive) and GTP-bound (active) states under control of GEFs (including Tiam1, Vav, Sos1, DOCK2/Vav, Vav2/p120-catenin, alsin), GAPs (including α1-chimaerin, CYK4/centralspindlin, SptP, β2-chimaerin), RhoGDI, ubiquitin-dependent degradation (promoted by caveolin-1), and post-translational modifications including geranylgeranylation (which restrains effector interactions), glutathiolation of Cys18 (which promotes nucleotide exchange), and PAK-dependent phosphorylation; once GTP-loaded, active Rac1 immobilizes in nanoclusters at the plasma membrane through its polybasic tail interacting with PIP2/PIP3, and at the lamellipodium tip interacts with the WAVE regulatory complex (WRC/Scar) to drive actin branching and membrane protrusion, while additional effectors including IQGAP1 (which scaffolds Rac1 with CLIP-170 to capture microtubule plus-ends for cell polarization), PAK1/2 (downstream of which BCL-6 repression, NF-κB activation, and stem-cell c-Myc regulation are mediated), PI3K, and the gp130/Stat3 axis link Rac1 to cell survival, proliferation, transcription (including Il17a via a nuclear Tiam1/Rac1/RORγt complex), NADPH oxidase activation (through gp91phox/p67phox interaction), and organelle-specific functions including ARF6-dependent endocytosis modulated by calmodulin, mitochondrial dynamics, and TrkA endosome trafficking in axons.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RAC1 is a Rho-family small GTPase that cycles between GDP-bound and GTP-bound states to orchestrate actin-dependent membrane remodeling, cell polarity, migration, survival, and lineage-specific transcriptional programs [#7, #16, #35]. Its activity is set spatially: GTP-loaded Rac1 partitions into plasma-membrane nanoclusters through its polybasic tail engaging PIP2/PIP3 [#16], and transient effector-dependent immobilizations at the lamellipodium tip drive WAVE regulatory complex (WRC)-dependent actin branching and membrane protrusion, a process locally restrained by the Rac1-binding suppressor CYRI/Fam49, which limits Scar/WAVE recruitment [#34, #35]. Active Rac1 also captures microtubule plus-ends for polarization by forming a Rac1–IQGAP1–CLIP-170 complex, and IQGAP1 binding both sustains GTP-loading and, for non-prenylated Rac1, routes it to ubiquitin-dependent degradation [#0, #18, #33, #44]. Rac1 activity is controlled by GEFs (Sos1, Vav/Vav2, DOCK2, alsin, Tiam1, β-PIX), GAPs (α1-/β2-chimaerin, centralspindlin CYK4, bacterial SptP and YopE), caveolin-1-promoted ubiquitin-dependent degradation, geranylgeranylation that restrains effector engagement, and Cys18 glutathiolation that promotes nucleotide exchange [#1, #13, #14, #17, #22, #30, #31, #33, #42]. Downstream, Rac1 engages PAK to regulate c-Myc-dependent epidermal stem cell fate, controls NADPH oxidase by promoting gp91phox–p67phox assembly, supports PI3K-dependent survival/anoikis resistance, and acts in the nucleus with Tiam1 and RORγt to activate the Il17a promoter [#9, #10, #23, #25]. Genetic studies establish non-redundant, isoform-specific roles in hematopoietic stem cell engraftment, Schwann cell myelination, chondrogenesis, axon growth, synaptic plasticity, and cardiac hypertrophy [#8, #9, #10, #24, #41]. Beyond these characterized axes, the corpus does not establish a unifying structural model of Rac1 nanocluster assembly.\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that GAP-driven inactivation of Rac1 is a negative regulator of actin cytoskeletal architecture, defining the functional consequence of switching Rac1 off.\",\n      \"evidence\": \"Stable α1-chimaerin expression with in-extract Rac1 GAP assay and actin/vinculin/adhesion phenotyping in NIH3T3 cells\",\n      \"pmids\": [\"7534315\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single GAP studied; spatial control of GAP action not addressed\", \"Effectors linking Rac1 to stress fibers/adhesion not identified here\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Placed Rac1 as an obligate effector linking the Vav GEF to the JNK/SAPK kinase cascade and oncogenic transformation, connecting Rac1 to stress-kinase signaling.\",\n      \"evidence\": \"Dominant-negative Rac1 N17 epistasis with JNK/SAPK kinase assay and focus formation in COS-7/NIH3T3\",\n      \"pmids\": [\"8760286\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intermediate kinases between Rac1 and JNK not defined\", \"Dominant-negative approach cannot exclude effects on related GTPases\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Demonstrated conformation-specific Rac1 binding to tubulin requiring the active state but not GTP hydrolysis, an early link between Rac1 and the microtubule system.\",\n      \"evidence\": \"GTP-overlay binding, purified tubulin reconstitution, and effector-domain (D38A) plus GTPase-dead mutagenesis\",\n      \"pmids\": [\"8631991\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular relevance of direct tubulin binding not established\", \"Relationship to IQGAP1/CLIP-170 microtubule capture unresolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed Rac1 is required for FcγR-mediated phagocytosis acting downstream of F-actin recruitment, distinguishing actin nucleation from membrane remodeling.\",\n      \"evidence\": \"Dominant-negative Rac1 N17 with F-actin staining and phagocytosis assays in macrophages\",\n      \"pmids\": [\"9348306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effectors mediating membrane remodeling not identified\", \"Mechanism of cup closure unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Refined the phagocytic role by showing Rac1 and Cdc42 perform distinct membrane/actin functions and coordinate phosphotyrosine resolution around particles.\",\n      \"evidence\": \"Stable dominant-negative Rac1/Cdc42 lines with morphology and phosphotyrosine imaging in RBL-2H3 mast cells\",\n      \"pmids\": [\"9799231\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the Rac1-vs-Cdc42 morphological divergence not defined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the Rac1 polybasic C-terminus as a GTP-independent docking site for lipid kinases, linking Rac1 to local phosphoinositide metabolism and RhoGDI handoff.\",\n      \"evidence\": \"In vitro binding with Rac1 chimeras/peptides, co-purification, and RhoGDI co-IP\",\n      \"pmids\": [\"9447972\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional output of the lipid-kinase complex on Rac1 signaling not tested\", \"Single-lab biochemistry\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed a bacterial effector (SptP) directly inactivates Rac1 as a GAP, providing biochemical proof that GTP hydrolysis reverses Rac1-driven cytoskeletal changes.\",\n      \"evidence\": \"In vitro GAP assay with purified SptP and Rac1/Cdc42 plus cellular phenotypic rescue\",\n      \"pmids\": [\"10499590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Host GAP equivalents not addressed here\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that membrane recruitment of active Rac1 alone suffices for actin polymerization and internalization, and that effector binding (F37 loop) is essential.\",\n      \"evidence\": \"Rapamycin-inducible membrane recruitment with effector-loop mutagenesis and bead internalization\",\n      \"pmids\": [\"10934035\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the essential effector not pinned down in this system\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified PI3K as the survival-relevant branch downstream of active Rac1 in anoikis resistance, separating survival from ERK/p38/NF-κB outputs.\",\n      \"evidence\": \"Rac1-V12 expression in suspended MDCK cells with caspase/DNA-fragmentation readouts and pathway inhibitors\",\n      \"pmids\": [\"11369774\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Rac1–PI3K link mechanism not shown\", \"Gain-of-function only\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the Rac1/Cdc42–IQGAP1–CLIP-170 tripartite complex that captures microtubule plus-ends to establish a single leading edge, connecting Rac1 to polarity.\",\n      \"evidence\": \"Reciprocal co-IP, GFP live imaging, and IQGAP1 binding-mutant expression in fibroblasts\",\n      \"pmids\": [\"12110184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How active Rac1 is spatially restricted to one edge not resolved here\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Genetically resolved non-redundant Rac1-vs-Rac2 functions, assigning HSC/progenitor retention and engraftment to Rac1 and oxidase/migration to Rac2.\",\n      \"evidence\": \"Conditional single and double Rac1/Rac2 knockouts with transplantation, oxidase, and migration assays in mice\",\n      \"pmids\": [\"14564009\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of isoform specificity not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Placed Rac1 upstream of PAK2 and c-Myc in epidermal stem cell fate, showing Rac1 restrains stem-cell differentiation.\",\n      \"evidence\": \"Inducible epidermal Rac1 KO with BrdU, c-Myc/PAK2 staining and epistasis in mice\",\n      \"pmids\": [\"16081735\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PAK2 substrate driving c-Myc regulation not identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed Rac1/Cdc42 drive chondrocyte hypertrophy and apoptosis via p38 MAPK, antagonizing RhoA, linking Rac1 to skeletal cell-fate transitions.\",\n      \"evidence\": \"Gain-of-function plus p38 inhibitor epistasis with reporter, TUNEL, and phospho-p38 in chondrocytes\",\n      \"pmids\": [\"15883643\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous Rac1 requirement not genetically tested here\", \"Single lab\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated bacterial YopE/YopT generate spatially distinct Rac1 pools, revealing membrane vs cytoplasmic/nuclear Rac1 activation states.\",\n      \"evidence\": \"FRET Rac1 biosensor imaging during infection with YopE/YopT mutant Yersinia\",\n      \"pmids\": [\"16228016\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear Rac1 GEFs not identified\", \"Single-lab live-imaging study\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected Rac1 to cardiac NADPH oxidase by showing Rac1 is required for gp91phox–p67phox assembly and angiotensin-II-induced hypertrophy.\",\n      \"evidence\": \"Cardiomyocyte-specific Rac1 KO with oxidase co-IP, activity, ROS, and echocardiography\",\n      \"pmids\": [\"16651530\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Rac1 contact within the oxidase complex not mapped here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined a p66shc–Sos1–Eps8–E3b1 module that enhances Rac1-specific GEF activity and oxidative stress, linking Rac1 activation to redox signaling.\",\n      \"evidence\": \"In vitro GEF assay, reciprocal co-IP, CH2 domain mapping, and Rac1-GTP pulldown\",\n      \"pmids\": [\"16520382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger of this module not defined here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified DGKγ as an upstream catalytic suppressor of Rac1 controlling lamellipodia, expanding lipid control of Rac1.\",\n      \"evidence\": \"DGKγ kinase-dead/active mutants, co-IP, dominant-negative Rac1 epistasis, and activation assays\",\n      \"pmids\": [\"15102830\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GEF/GAP intermediary between DGKγ and Rac1 not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established alsin as a Rac1 GEF supporting motoneuron survival and axon growth, with Rac1 (not Rab5) as the relevant effector.\",\n      \"evidence\": \"Alsin siRNA with dominant-negative/active Rac1 and Rab5 rescue in motoneurons\",\n      \"pmids\": [\"16802292\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream survival effectors not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed both loss and gain of Rac1 activity drive premature senescence via ROS and p53, identifying a homeostatic Rac1 activity window.\",\n      \"evidence\": \"Rac1-targeted and L61Rac1 MEFs with ROS, γH2AX, p53 phosphorylation, and p53-deletion epistasis\",\n      \"pmids\": [\"17032649\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ROS source linking Rac1 to p53 not defined here\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placed β-PIX downstream of ILK and upstream of Rac1 in integrin-mediated spreading, defining an adhesion-coupled activation route.\",\n      \"evidence\": \"ILK–PKL–β-PIX co-IP, dominant-negative β-PIX and siRNA epistasis, Rac1-GTP pulldown\",\n      \"pmids\": [\"16723384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct β-PIX nucleotide exchange on Rac1 not isolated here\", \"Single lab\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapped Rac1 switch-region determinants (Asp63/Arg68/Leu70, residues 32/36) that distinguish IQGAP1 binding from Cdc42 and partially overlap GAP sites.\",\n      \"evidence\": \"Systematic Rac1/Cdc42 mutagenesis with quantitative binding and competition assays\",\n      \"pmids\": [\"17984089\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In-cell consequences of selective interface mutations not tested here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed Rac1 promotes chondrogenesis and N-cadherin/Sox9 expression, extending its role to mesenchymal differentiation.\",\n      \"evidence\": \"Pharmacologic inhibition, dominant-active overexpression, and conditional KO micromass cultures with RT-PCR/immunoblot\",\n      \"pmids\": [\"17573353\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Effector pathway from Rac1 to Sox9 not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified a β-PIX–Rac1 module mediating NOD2 membrane trafficking and negative feedback via Erbin in innate immune signaling.\",\n      \"evidence\": \"Rac1 activation assay, NOD2–β-PIX–Rac1 co-IP, siRNA, and NOD2 localization/NF-κB readouts\",\n      \"pmids\": [\"18684957\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Rac1 GTP-loading is required vs scaffolding not separated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined gp130/Stat3 as an essential effector axis downstream of active Rac1 driving migration and proliferation.\",\n      \"evidence\": \"Rac1-V12 expression with gp130 siRNA, Stat3 reporter, and proliferation/migration assays\",\n      \"pmids\": [\"19852956\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Rac1-induced IL-6 upregulation not defined\", \"Gain-of-function only\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked Rac1 to transcriptional derepression by showing PAK1 phosphorylates and inactivates BCL-6, with isoform-selective behavior of Rac1 vs Rac1b.\",\n      \"evidence\": \"Active Rac1 mutants, NSC23766 inhibition, BCL-6 fractionation, and in vitro PAK1 kinase assay on BCL-6\",\n      \"pmids\": [\"19487462\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous physiological context of BCL-6 regulation not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed CCK activates Rac1 through cooperative Gα13/Gαq signaling independent of PLC, defining a GPCR route to Rac1 in acinar cells.\",\n      \"evidence\": \"Active Gα constructs, RGS inhibitors, and Rac1/RhoA activation assays\",\n      \"pmids\": [\"19940064\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GEF coupling Gα proteins to Rac1 not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed a non-canonical termination mechanism in which caveolin-1 directs ubiquitin-proteasomal degradation of GTP-bound Rac1 in an adhesion-dependent manner.\",\n      \"evidence\": \"Cav1 co-IP, Cav1-KO fibroblasts, ubiquitylation assay, and ubiquitylation-deficient Rac1 mutant\",\n      \"pmids\": [\"20460433\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase responsible for Rac1 ubiquitylation not identified here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated high-affinity Rac1–calmodulin binding via the polybasic/prenyl region controls ARF6-dependent clathrin-independent endocytosis and PIP5K recruitment.\",\n      \"evidence\": \"Binding measurements, CaM inhibition, active/inactive Rac1 mutants, and PI4,5P2 tubulation/endocytosis assays\",\n      \"pmids\": [\"21883766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological cargo of this endocytic route not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed mTOR–S6K1 upstream of Rac1 in platelet spreading via an S6K1–Rac1–TIAM1 complex independent of Src/FAK.\",\n      \"evidence\": \"Co-IP of the tricomplex with mTOR/S6K1/Src/FAK inhibitor epistasis and spreading assays\",\n      \"pmids\": [\"21757621\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether S6K1 acts catalytically on the GEF not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved sequential Rap1→Rac1 signaling with Rac1 positive feedback onto Rap1, defining two Rac1 pools in platelet activation.\",\n      \"evidence\": \"EHT1864 inhibition, CalDAG-GEFI/P2Y12 double-KO mice, activation assays, and clot retraction\",\n      \"pmids\": [\"22075250\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GEFs defining the two Rac1 pools not separately identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established CYK4/centralspindlin as a Rac1-specific GAP that spatially segregates adhesion (ARHGEF7/PAK1) from the contractile ring during cytokinesis.\",\n      \"evidence\": \"In vitro GAP assay, GAP-mutant expression, and ARHGEF7/PAK1 depletion rescue with cytokinesis phenotyping\",\n      \"pmids\": [\"22945935\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CYK4 GAP activity is spatially confined to the equator not fully resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified a nuclear Tiam1/Rac1/RORγt complex that activates the Il17a promoter, giving Rac1 a direct transcriptional role in Th17 immunity.\",\n      \"evidence\": \"Co-IP, ChIP at Il17, T-cell-specific Rac1 KO, EAE model, and pharmacologic inhibition\",\n      \"pmids\": [\"27725632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How nuclear Rac1 is recruited/retained not defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed Wnt3a activates Rac1 through CK1-dependent p120-catenin release from E-cadherin enabling a p120/Vav2/Rac1 complex, linking cadherin junctions to Rac1.\",\n      \"evidence\": \"Co-IP of p120/Vav2/Rac1, phosphorylation dissection, and Xenopus depletion/rescue\",\n      \"pmids\": [\"22946057\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct catalytic step of Vav2 on Rac1 in this complex not isolated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated Rac1 is required for Schwann cell myelination acting upstream of PAK, NF2/merlin, and cAMP, with genetic and pharmacologic rescue.\",\n      \"evidence\": \"Conditional Rac1 KO, phospho-PAK/merlin immunoblots, NF2 mutant rescue, and rolipram rescue in mice\",\n      \"pmids\": [\"23197717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Rac1 lowers cAMP mechanistically not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed GluN3A-NMDARs sequester GIT1 to limit β-PIX/Rac1/PAK signaling and spine growth, an activity-regulated brake on Rac1 in synapses.\",\n      \"evidence\": \"GluN3A–GIT1 co-IP, KO mice, shRNA, Rac1 activation assay, and spine morphology\",\n      \"pmids\": [\"24297929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of GluN3A–GIT1 competition with β-PIX not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified Cys18 glutathiolation as a redox switch that promotes Rac1 nucleotide exchange and activation, linking oxidative state to GTP-loading.\",\n      \"evidence\": \"Mass spectrometry, in vitro nucleotide exchange on oxidized Rac1, pKa measurement, and C18 mutants with cellular validation\",\n      \"pmids\": [\"25289457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological oxidant source for endogenous Cys18 modification not pinned\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined Rac1 plasma-membrane nanoclusters formed via polybasic-tail/PIP2-PIP3 binding and enriched in protrusions, establishing spatial nanodomain organization of Rac1 signaling.\",\n      \"evidence\": \"Single-molecule tracking and super-resolution imaging with lipid perturbation\",\n      \"pmids\": [\"29141223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Compositional census of nanocluster effectors incomplete\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed Rac1 spatial gradients are shaped by localized GEF/GAP activity—specifically β2-chimaerin at the tip—rather than transport, controlling migration speed.\",\n      \"evidence\": \"Optogenetic GEF recruitment, FRET biosensors, micropatterning, and β2-chimaerin KO/depletion\",\n      \"pmids\": [\"30446664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Feedback wiring localizing β2-chimaerin not fully resolved molecularly\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified CYRI/Fam49 as a Rac1-binding suppressor of Scar/WAVE that limits protrusion size and tunes chemotaxis and polarity.\",\n      \"evidence\": \"DUF1394–Rac1 binding, CYRI KO/overexpression, optogenetic Rac1 activation, and Scar/WAVE imaging\",\n      \"pmids\": [\"30054448\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CYRI competes with WRC at the molecular interface not fully mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed postsynaptic α2δ-1 is required and sufficient for thrombospondin-induced synaptogenesis via Rac1, linking a synaptogenic cue to Rac1.\",\n      \"evidence\": \"Cell-type-specific α2δ-1 KO, Rac1 activation assay, EM, and in vivo spine counts\",\n      \"pmids\": [\"30054448\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GEF coupling α2δ-1 to Rac1 not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established that prenylation by GGTase-I restrains Rac1, with non-prenylated Rac1 binding IQGAP1 to drive exchange and degradation and to fuel inflammation.\",\n      \"evidence\": \"Rac1+/- and IQGAP1 KO genetic rescue in GGTase-I-deficient mice with co-IP/ubiquitination and GTP-loading assays\",\n      \"pmids\": [\"31484924\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase for non-prenylated Rac1 not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated that short-lived, effector-dependent Rac1 immobilizations at the lamellipodium tip trigger WRC-dependent actin branching needed for protrusion.\",\n      \"evidence\": \"Single-particle tracking, tip-localized optogenetic activation, and Rac1 effector-loop/WRC mutants\",\n      \"pmids\": [\"31422887\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism converting transient immobilization into sustained WRC output not fully defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed PKCα selectively promotes Rac1 activation during single-spine structural plasticity via its PDZ-binding domain.\",\n      \"evidence\": \"Two-photon uncaging, single-spine FRET biosensors, PKCα shRNA, and PDZ mutant\",\n      \"pmids\": [\"32019972\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GEF/effector linking PKCα to Rac1 not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed local prenylation of newly synthesized Rac1 targets it to TrkA endosomes to drive axonal receptor trafficking and target innervation.\",\n      \"evidence\": \"Conditional GGTase KO in sympathetic neurons, compartmentalized prenylation assays, and TrkA endosome imaging\",\n      \"pmids\": [\"32533921\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effectors mediating Rac1's endosomal trafficking role not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed IQGAP1 sustains VEGF-induced Rac1 activation via VEGFR2–Src to drive endothelial migration and choroidal neovascularization.\",\n      \"evidence\": \"IQGAP1 KO mice, Rac1-binding-deficient mutant, Rac1-GTP pulldown, and CNV model\",\n      \"pmids\": [\"32783108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How IQGAP1 binding extends GTP-loading kinetically not fully resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Placed Rac1 within Hedgehog signaling, where Smo–Vav2-activated Rac1 phosphorylates KIF3A, stabilizes IFT88, and enables Gli nuclear translocation.\",\n      \"evidence\": \"Smo–Vav2 co-IP, Rac1 activation, KIF3A phosphorylation, IFT88 stability, SuFu–Gli co-IP, and Rac1 conditional KO mice\",\n      \"pmids\": [\"35154488\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect Rac1 phosphorylation of KIF3A not separated\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unifying structural and quantitative model integrating Rac1's lipid-anchored nanocluster assembly, prenylation/glutathiolation switches, and the combinatorial GEF/GAP code that selects among its many effector and transcriptional outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No single model reconciles spatial nanodomain control with effector selection\", \"E3 ligase(s) for ubiquitin-dependent Rac1 turnover not identified across contexts\", \"Determinants of nuclear vs membrane Rac1 function not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [1, 13, 30, 42]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [4, 7, 35, 36]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [5, 16, 43]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 16, 19, 35, 43]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [19, 23, 37]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 6, 35]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [41, 43]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 14, 26, 45]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 3, 8, 23, 27]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [23, 37, 45]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 11, 24, 41, 45]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 3, 27, 41, 43]}\n    ],\n    \"complexes\": [\n      \"Rac1–IQGAP1–CLIP-170 complex\",\n      \"WAVE regulatory complex (WRC/Scar)\",\n      \"Tiam1/Rac1/RORγt nuclear complex\",\n      \"gp91phox/p67phox NADPH oxidase complex\"\n    ],\n    \"partners\": [\n      \"IQGAP1\",\n      \"Tiam1\",\n      \"Vav2\",\n      \"PAK1\",\n      \"CYRI/Fam49\",\n      \"caveolin-1\",\n      \"calmodulin\",\n      \"β-PIX\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}